Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
AGBL3	"CCP3, MGC32955"	ENSG00000146856	"ATP/GTP binding protein like 3"	Q8NEM8	7	134986508-135147963	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 8.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020397, HPA024150"	Uncertain		Uncertain	"Nuclear speckles,Mitochondria,Cytosol"				"Nuclear speckles, Mitochondria, Cytosol"		"HPA020397: AB_2242453, HPA024150: AB_1844639"	"unprognostic (8.84e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.32e-3)"	"unprognostic (4.18e-2)"	"unprognostic (7.15e-4)"	"unprognostic (5.00e-3)"	"unprognostic (6.10e-4)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (4.02e-4)"	"unprognostic (2.18e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.11e-3)"	3.2	2.7	4.2	4.1	8.4	3.8	4.6	8.7	4.5	4.3	2.4	4.4	4.5	1.6	5.5	15.4	2.2	3.6	3.1	2.4	5.0	3.4	5.3	2.6	3.6	4.0	2.7	4.5	6.8	4.5	0.6	9.2	1.9	3.3	3.8	3.0	3.1	4.9	4.3	4.2	4.7	3.7	3.3	2.9	6.5	4.4	18.7	3.7	2.7	5.4	0.8	2.8	3.3	2.5	2.2	1.7	0.5	0.2	2.2	5.0	1.7	2.6	1.4	3.6	0.8	1.0	1.4	2.2	0.7	0.0	0.5	0.8	4.7	3.0	4.3	1.3	0.0	2.8	1.3	0.5	0.0	3.4	8.8	3.6	5.3	4.6	0.0	1.6	0.0	0.2	0.0	2.1	0.0	1.5	2.6	2.5	0.6	2.5	0.9	1.5	3.1	0.3	2.5	0.2	1.2	2.6	0.5	2.1	2.4	0.5	0.0	0.3	1.9	3.5	0.0	0.4	0.9	0.5	1.6	5.3	1.6	1.9	1.8	4.3	4.4	0.0	0.2	0.4	2.4	0.0	1.8	2.1	1.2	2.5	0.5	2.2	2.0	5.0	0.5	2.2	0.1	1.7	1.7	1.7	4.2	8.4	8.7	4.5	5.0	3.4	2.7	4.5	3.3	3.7
AK6	CINAP	ENSG00000085231	"Adenylate kinase 6"	Q9Y3D8	5	69350984-69370013	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005361, HPA070217"	Supported		Supported	"Nuclear speckles,Centrosome,Cytosol"				"Nuclear speckles"	"Centrosome, Cytosol"	"CAB005361: AB_2302969, HPA070217: "	"unprognostic (5.47e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavourable (9.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	27.6	27.7	25.1	16.9	25.4	14.8	23.3	21.5	23.6	17.6	22.7	11.3	16.4	18.3	18.3	30.4	26.7	15.4	15.1	17.9	23.2	22.2	30.2	42.3	17.0	18.7	20.9	16.2	18.8	17.2	15.8	26.3	21.5	23.3	18.2	20.6	12.3	14.5	14.6	41.4	11.9	24.0	16.7	19.6	21.8	17.0	46.1	17.5	25.2	24.3	24.2	18.8	19.7	13.7	22.2	22.0	14.3	15.9	16.6	21.2	10.0	17.2	9.6	12.6	16.8	20.7	13.8	23.7	26.0	9.8	12.8	15.9	26.8	14.9	37.0	24.6	11.8	5.8	19.7	12.4	19.6	15.1	9.5	18.2	20.5	20.4	16.9	21.6	7.9	8.0	16.4	12.7	18.3	8.3	17.0	12.2	16.4	20.0	19.9	14.6	10.5	6.4	23.4	15.7	20.5	20.1	14.1	6.5	6.4	13.4	10.8	18.6	11.5	24.4	10.9	9.6	15.4	17.9	21.5	14.7	30.6	32.8	12.4	31.8	12.4	13.7	13.0	14.3	15.5	15.9	16.1	22.2	18.4	19.3	18.0	18.1	20.1	21.2	2.1	16.6	14.2	22.0	18.1	10.0	25.1	25.4	21.5	23.6	23.2	22.2	20.9	16.2	23.3	17.5
ANKRD55	FLJ11795	ENSG00000164512	"Ankyrin repeat domain 55"	Q3KP44	5	56099678-56233359	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"blood: 14.3;brain: 20.0;liver: 5.7;lymphoid tissue: 6.1;testis: 16.7"	"Group enriched"	"Detected in some"	6	"HEL: 23.9;HMC-1: 12.4;NB-4: 15.7"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 12.6;eosinophil: 13.1;naive CD4 T-cell: 14.3"	"Group enriched"	"Detected in many"	67	"granulocytes: 13.1;T-cells: 14.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA051049, HPA061649"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA051049: , HPA061649: "	"unprognostic (1.00e-4)"	"unprognostic (1.58e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.78e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.19e-6)"	"unprognostic (2.56e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.01e-1)"	0.9	0.5	3.3	1.3	20.0	1.4	0.5	0.5	6.7	0.3	0.5	1.5	0.0	0.5	0.3	0.2	0.6	0.6	0.8	0.4	4.3	7.8	1.1	5.7	0.6	6.1	2.3	3.5	0.5	0.3	0.2	0.5	1.4	9.9	0.3	0.7	0.7	2.1	0.3	0.3	0.9	2.4	0.5	4.1	3.0	0.7	16.7	1.8	0.0	0.4	0.0	3.8	1.0	0.3	0.0	0.0	13.1	0.2	0.0	14.3	2.1	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.1	0.9	0.0	1.1	12.4	0.0	0.0	0.0	0.0	3.0	1.9	0.8	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	1.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.4	0.3	12.6	0.2	13.1	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	14.3	0.5	1.2	0.0	0.0	0.0	0.6	2.1	3.3	20.0	0.5	6.7	4.3	7.8	2.3	3.5	9.9	1.8
ARHGAP18	"bA307O14.2, MacGAP"	ENSG00000146376	"Rho GTPase activating protein 18"	Q8N392	6	129576132-129710225	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 91.0;LHCN-M2: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031595	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"			840000	"Plasma membrane, Cytosol"	"Nuclear speckles"	"HPA031595: AB_10959905"	"unprognostic (6.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.12e-2)"	"prognostic unfavourable (2.54e-4)"	"unprognostic (4.08e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.05e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.08e-1)"	23.8	32.2	4.1	14.1	4.0	1.7	19.7	2.5	2.4	9.6	19.5	2.9	12.0	13.3	7.8	25.8	5.8	15.7	11.8	16.9	4.4	6.8	33.2	4.5	38.8	15.5	4.1	1.4	8.0	38.2	10.6	22.0	16.7	12.2	9.6	8.2	10.4	16.7	24.2	12.1	5.4	40.6	6.5	9.0	15.8	15.1	10.9	3.8	5.1	12.7	12.1	6.4	10.3	5.8	2.9	11.8	13.0	5.9	2.5	5.8	6.0	1.8	4.2	0.4	0.5	4.1	5.9	3.4	14.3	11.0	6.3	4.3	2.2	3.1	1.5	7.0	9.6	2.4	3.0	4.7	11.9	1.5	1.3	10.2	3.3	12.5	5.9	1.5	91.0	3.7	0.7	11.5	10.3	18.0	5.4	3.9	25.6	0.5	0.0	1.4	0.4	1.0	0.0	1.9	2.9	19.3	1.0	0.0	0.0	1.1	2.0	7.0	2.2	1.8	13.7	6.6	0.9	0.5	11.4	1.8	1.3	1.0	2.2	2.8	9.2	8.9	5.2	13.0	5.3	5.9	3.3	2.9	2.8	5.8	4.8	1.7	0.5	2.9	4.0	2.5	3.1	11.8	2.7	6.0	4.1	4.0	2.5	2.4	4.4	6.8	4.1	1.4	12.2	3.8
ARMCX5	"FLJ12969, GASP5"	ENSG00000125962	"Armadillo repeat containing, X-linked 5"	Q6P1M9	X	102599168-102604159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000996	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles, Cytosol"	"Plasma membrane"	"HPA000996: AB_1078212"	"unprognostic (7.71e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.07e-2)"	"prognostic favourable (6.58e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.24e-2)"	8.6	13.2	11.4	7.0	17.3	6.4	13.8	24.3	19.8	11.2	9.5	8.7	13.1	7.9	13.3	12.5	10.1	11.9	7.5	7.8	11.1	6.3	10.0	15.5	8.3	6.9	8.1	12.9	16.5	25.3	14.5	26.4	6.1	12.8	16.6	11.9	9.2	13.4	11.0	6.1	9.9	10.4	10.8	7.0	10.2	11.7	6.1	8.4	9.5	15.3	7.0	9.6	10.4	9.8	9.7	9.3	2.5	9.8	7.1	15.9	8.5	8.0	7.3	17.2	9.1	7.7	8.7	9.7	7.9	6.1	9.3	16.6	8.6	10.0	0.0	9.7	7.9	7.0	15.3	7.5	10.6	0.0	6.1	8.1	9.2	7.1	10.0	14.7	9.5	10.8	9.8	8.0	9.7	9.4	7.8	0.0	12.3	7.1	10.4	1.7	7.7	13.8	10.3	42.2	0.0	6.9	11.2	8.2	7.3	14.2	7.4	11.3	5.1	7.1	9.5	6.9	6.2	7.8	5.6	0.0	5.7	0.0	5.4	15.1	17.7	0.0	9.5	2.5	12.0	9.8	11.5	9.7	11.3	9.4	9.3	6.0	15.9	12.3	0.8	7.1	6.0	8.1	7.7	8.5	11.4	17.3	24.3	19.8	11.1	6.3	8.1	12.9	12.8	8.4
C10orf67	"bA215C7.4, C10orf115, LINC01552, MGC46732"	ENSG00000179133	"Chromosome 10 open reading frame 67"	Q8IYJ2	10	23201916-23344845	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 7.3;pituitary gland: 9.0;testis: 13.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 5.2;SiHa: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.2"	"Low lineage specificity"	"Detected in many"											"HPA038130, HPA038131"	Approved		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles"				Nucleoplasm	"Nucleoli, Nuclear speckles"	"HPA038130: , HPA038131: AB_10670658"	"unprognostic (4.76e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.92e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.91e-1)"		"unprognostic (1.54e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.98e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.84e-3)"	"unprognostic (9.58e-2)"	0.1	0.1	1.3	1.7	2.6	0.2	0.0	0.1	1.9	0.3	0.5	0.4	1.3	0.5	0.2	4.6	0.1	7.3	0.2	3.2	1.6	1.4	5.0	0.5	4.0	0.3	0.9	0.5	1.8	0.3	0.4	9.0	0.1	1.2	0.1	0.0	0.2	0.1	0.1	0.6	1.9	0.4	0.0	0.7	0.2	0.1	13.8	0.6	0.0	0.6	0.7	0.1	0.1	0.1	1.1	1.1	1.0	0.5	1.1	4.2	0.0	1.5	0.1	1.9	0.2	0.0	0.5	0.4	0.2	0.1	2.0	1.6	0.1	2.4	0.2	0.2	1.5	5.2	0.2	0.7	1.6	0.5	0.4	0.1	0.7	0.3	1.0	0.1	0.0	0.6	1.7	0.6	1.0	0.0	0.2	0.7	0.0	0.3	0.1	0.5	0.9	0.1	0.1	0.2	0.4	1.7	0.3	0.9	0.4	8.4	0.3	0.1	0.3	0.3	0.2	0.4	1.5	0.4	0.1	1.0	0.2	0.1	2.5	0.2	0.1	1.0	0.5	0.6	0.7	0.3	0.6	1.1	1.5	0.8	0.1	1.0	1.1	1.0	0.8	1.1	0.3	1.1	4.2	0.0	1.3	2.6	0.1	1.9	1.6	1.4	0.9	0.5	1.2	0.6
C16orf70	"C16orf6, FLJ12076, lin-10, LIN10"	ENSG00000125149	"Chromosome 16 open reading frame 70"	Q9BSU1	16	67109958-67148539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041131, HPA041214"	Approved		Approved	"Nucleoli fibrillar center,Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nucleoli fibrillar center, Cytosol"	"HPA041131: AB_10795487, HPA041214: AB_10794267"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.15e-2)"	8.0	7.7	11.3	6.7	14.6	14.2	10.5	14.0	22.4	8.4	7.9	24.2	8.6	6.7	8.9	8.8	12.5	10.1	8.2	8.0	12.6	8.9	11.8	43.2	7.9	7.6	18.2	13.1	10.1	6.2	19.5	8.3	10.6	15.5	12.9	9.4	7.7	8.9	8.4	20.1	22.0	7.1	10.0	18.0	11.2	6.9	10.6	16.0	7.0	7.1	5.8	10.3	8.4	10.3	7.2	14.1	6.3	15.9	5.2	8.3	7.3	6.7	10.1	9.7	10.1	12.3	7.4	22.9	7.7	8.4	15.7	17.3	11.2	6.0	6.8	6.8	9.1	9.1	12.0	7.6	20.4	3.6	11.0	5.4	6.4	23.4	7.6	5.2	30.0	7.3	10.6	15.3	7.2	8.8	8.7	2.9	9.6	6.8	10.2	8.2	10.7	16.5	14.3	16.8	10.7	6.9	4.1	12.6	6.8	23.9	5.5	5.8	11.0	4.5	6.7	11.2	9.5	7.9	6.6	4.5	8.1	20.4	10.1	5.5	8.8	2.9	15.9	5.4	4.7	11.8	6.2	7.2	7.0	8.3	14.1	4.9	7.1	6.6	6.3	5.2	11.8	4.6	6.7	7.3	11.3	14.6	14.0	22.4	12.6	8.9	18.2	13.1	15.5	16.0
C1orf35	"MGC4174, MMTAG2"	ENSG00000143793	"Chromosome 1 open reading frame 35"	Q9BU76	1	228100726-228105411	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046175	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles, Plasma membrane"	Cytosol	"HPA046175: AB_10959459"	"unprognostic (1.12e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavourable (7.71e-4)"	"unprognostic (6.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.39e-1)"	"prognostic favourable (7.38e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (1.79e-6)"	"unprognostic (2.70e-1)"	"unprognostic (8.58e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.70e-2)"	10.1	12.7	14.3	15.6	17.0	12.7	12.0	23.9	15.7	12.5	11.2	11.6	16.1	12.5	13.7	10.6	17.3	14.9	8.1	8.0	13.8	10.0	10.6	10.2	11.0	12.5	17.7	13.6	19.0	21.0	12.5	10.0	12.4	15.0	13.2	6.4	10.4	19.1	16.1	14.0	24.1	11.3	13.3	9.2	12.6	13.2	8.8	13.2	14.6	12.4	6.9	12.0	12.8	13.9	20.2	26.7	21.9	18.4	17.6	21.5	10.3	9.5	10.7	6.8	4.1	3.7	3.8	16.0	7.4	3.4	6.6	4.8	9.6	9.1	9.3	16.0	2.5	10.7	6.4	7.1	2.4	10.6	34.1	5.8	7.4	9.4	6.2	12.9	7.3	3.3	8.5	6.3	6.1	7.2	14.7	5.2	4.9	11.3	17.2	16.5	13.4	24.8	12.2	10.8	15.4	5.7	7.2	12.0	11.3	6.9	11.1	9.5	13.2	12.1	6.3	5.2	7.7	13.7	15.6	9.6	4.9	8.7	6.3	7.6	8.1	6.3	16.3	21.9	16.2	18.4	20.9	20.2	18.1	17.7	20.4	16.7	21.5	18.1	2.2	17.6	17.5	26.7	18.0	10.3	14.3	17.0	23.9	15.7	13.8	10.0	17.7	13.6	15.0	13.2
CACTIN	"C19orf29, cactin, fSAPc, NY-REN-24"	ENSG00000105298	"Cactin, spliceosome C complex subunit"	Q8WUQ7	19	3610641-3626815	"Predicted intracellular proteins"	"Immunity, Innate immunity, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042504, HPA042548"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA042504: AB_10797501, HPA042548: AB_10794760"	"unprognostic (1.18e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.09e-1)"	"prognostic favourable (3.69e-5)"	"unprognostic (5.93e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.22e-3)"	"unprognostic (3.88e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.55e-3)"	16.1	14.4	18.3	19.4	17.8	19.8	16.2	19.2	19.9	11.8	12.4	13.1	12.3	14.5	14.2	9.6	11.9	13.0	13.0	10.3	14.2	10.9	11.9	14.8	11.7	16.5	14.3	9.9	21.4	14.9	8.9	11.1	11.3	13.4	13.4	8.5	10.3	15.5	12.8	28.6	22.0	16.2	12.2	9.8	23.0	15.7	14.4	15.0	13.9	12.6	11.9	12.7	11.3	18.5	2.1	4.3	0.8	2.9	0.9	3.7	1.3	14.4	8.4	7.1	12.1	5.2	5.1	10.8	10.4	4.2	6.3	7.0	8.3	6.5	12.2	8.9	6.5	13.5	7.4	8.7	3.8	12.2	9.7	7.5	11.4	9.9	7.2	10.2	11.0	5.0	8.5	5.8	4.0	9.0	16.7	13.6	3.3	8.7	18.2	8.9	15.1	9.8	19.3	9.2	11.4	5.8	7.4	9.8	13.7	11.7	8.3	8.4	6.6	11.8	11.6	8.4	10.7	18.4	18.1	20.9	13.9	13.4	10.4	16.4	11.3	0.0	1.2	0.0	3.7	2.9	1.3	2.0	1.8	1.7	1.0	2.1	2.0	2.5	0.8	0.9	0.4	4.3	1.4	1.3	18.3	17.8	19.2	19.1	14.2	10.9	14.3	9.9	13.4	15.0
CHD5		ENSG00000116254	"Chromodomain helicase DNA binding protein 5"	Q8TDI0	1	6101793-6180123	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.4;pituitary gland: 22.3;testis: 16.4"	"Group enriched"	"Detected in some"	4	"SCLC-21H: 16.6;U-2 OS: 7.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015809			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA015809: "	"unprognostic (5.03e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.40e-6)"	"unprognostic (1.91e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.64e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.34e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	1.1	7.9	19.8	1.3	17.1	1.0	1.0	12.1	41.4	1.2	1.4	0.7	0.0	1.3	1.2	1.2	1.5	1.2	1.2	1.6	15.3	10.1	1.3	1.0	1.2	1.0	4.3	19.1	1.1	1.4	1.3	22.3	1.0	8.0	1.9	1.3	2.3	1.2	4.8	1.2	1.0	1.4	1.2	1.6	1.1	1.2	16.4	0.8	0.0	1.0	0.0	1.0	1.1	0.4	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.1	0.1	0.0	0.0	0.1	0.2	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.3	1.5	0.0	0.3	1.3	0.0	0.0	0.0	0.0	16.6	0.2	0.1	0.0	0.0	2.8	0.1	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.8	17.1	12.1	34.2	15.3	10.1	4.3	19.1	8.0	0.8
CHIC1	BRX	ENSG00000204116	"Cysteine rich hydrophobic domain 1"	Q5VXU3	X	73563200-73687102	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 18.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026782, HPA052062"	Uncertain		Approved	"Nuclear speckles,Vesicles,Cytosol"				"Nuclear speckles, Vesicles"	Cytosol	"HPA026782: AB_1846654, HPA052062: "	"unprognostic (9.85e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.10e-2)"	"unprognostic (9.95e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.65e-1)"	"prognostic favourable (2.75e-4)"	"unprognostic (1.37e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.76e-2)"	5.6	13.9	11.0	7.1	16.3	1.5	7.5	14.7	17.6	14.6	8.2	8.5	7.7	4.7	11.1	7.9	5.1	8.7	9.2	10.3	11.7	13.2	12.4	3.4	5.6	7.2	11.2	13.8	11.8	4.1	13.3	18.2	4.4	16.8	9.9	8.6	6.8	5.1	13.0	4.6	6.0	5.9	10.7	15.4	7.7	4.9	3.3	12.5	3.7	12.8	2.6	6.8	7.4	10.1	1.1	0.2	1.0	0.3	1.2	3.0	0.6	4.0	4.1	2.1	2.7	6.0	8.2	0.0	4.5	6.1	3.7	4.5	2.7	5.1	1.9	6.3	4.0	1.2	3.0	2.2	8.3	4.6	3.7	2.7	3.4	0.0	3.9	0.0	5.5	5.6	2.7	7.0	3.8	5.3	0.7	18.3	7.2	0.6	1.6	0.0	6.6	4.1	1.6	5.3	1.2	4.7	2.0	1.2	1.7	5.1	2.4	5.4	2.0	1.1	6.1	4.3	4.2	8.5	2.7	5.2	12.9	0.0	6.3	3.0	3.3	1.0	0.1	0.0	1.9	0.1	3.0	1.1	1.5	1.9	0.0	1.1	1.5	2.0	0.0	1.2	0.3	0.2	1.2	0.6	11.0	16.3	14.7	17.6	11.7	13.2	11.2	13.8	16.8	12.5
CKAP4	"CLIMP-63, ERGIC-63, P63"	ENSG00000136026	"Cytoskeleton associated protein 4"	Q07065	12	106237877-106304279	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 73.6;BJ hTERT+: 92.9;fHDF/TERT166: 110.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 34.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000278, HPA000792, HPA001225"	Enhanced		Uncertain	"Nuclear speckles,Cytosol,Cytoplasmic bodies"			11000	"Nuclear speckles, Cytosol"	"Cytoplasmic bodies"	"HPA000278: AB_1078527, HPA000792: AB_1078526, HPA001225: AB_2666241"	"unprognostic (5.25e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavourable (6.61e-5)"	"prognostic unfavourable (5.61e-4)"	"unprognostic (5.02e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.95e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.20e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.66e-2)"	13.0	23.8	7.1	15.3	4.9	39.5	27.2	6.9	8.4	42.3	19.2	6.5	24.8	8.1	23.7	35.2	47.3	17.2	26.6	32.9	5.7	8.0	18.3	42.1	22.2	28.5	6.3	5.4	28.6	55.2	12.7	12.0	30.6	6.8	23.9	20.5	13.2	34.4	28.0	11.1	20.8	10.7	20.4	5.8	16.7	23.0	10.3	4.2	4.0	18.6	30.0	27.8	25.8	21.4	4.2	2.3	34.6	7.5	0.1	1.0	2.4	11.2	14.2	17.2	18.7	33.6	30.0	10.0	73.6	92.9	36.0	41.5	6.0	2.6	0.7	13.4	110.9	20.5	12.6	11.1	25.9	0.3	7.3	0.0	8.2	11.8	25.1	0.1	0.2	28.7	15.3	30.5	22.1	42.1	0.0	1.4	34.1	3.8	0.5	0.4	10.0	17.3	5.2	12.4	0.9	10.9	10.2	5.7	6.3	13.1	8.9	7.0	10.0	5.1	35.9	28.4	15.7	11.7	20.8	3.9	0.0	8.0	20.5	1.4	24.8	34.6	7.5	8.7	0.5	2.7	0.7	4.2	0.7	0.4	2.3	1.6	1.0	0.9	12.7	0.1	4.1	0.0	0.2	2.4	7.1	4.9	6.9	8.4	5.7	8.0	6.3	5.4	6.8	4.2
CPD	GP180	ENSG00000108582	"Carboxypeptidase D"	O75976	17	30378905-30469989	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HSkMC: 57.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052796, HPA055465"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear speckles"			930000	"Nucleoplasm, Nuclear speckles"	"Nuclear membrane"	"HPA052796: , HPA055465: "	"unprognostic (1.05e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.97e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.25e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.08e-1)"	16.4	8.0	9.8	12.3	12.4	18.1	17.9	9.1	13.3	28.6	16.2	18.5	10.1	12.9	12.6	10.1	10.0	15.2	33.6	10.5	12.8	10.4	13.4	26.8	20.0	14.2	22.1	11.4	7.8	14.7	21.2	14.9	22.3	13.9	11.4	13.3	7.5	59.7	7.9	10.0	7.8	22.0	15.1	25.9	7.9	24.6	25.0	13.5	5.8	37.2	7.7	10.0	11.5	11.6	0.4	3.4	19.3	5.5	2.1	3.8	2.5	12.1	18.5	16.1	16.5	16.8	32.0	5.8	16.8	24.6	11.7	14.4	21.7	7.9	1.5	21.4	19.2	8.7	10.4	21.2	19.7	5.7	14.9	3.4	11.4	13.4	20.4	22.6	9.1	57.0	9.5	14.9	14.5	23.6	6.7	18.0	9.3	2.3	7.2	6.2	4.5	4.2	7.0	18.7	4.7	21.8	13.9	4.0	10.2	20.0	17.3	8.7	16.4	15.7	28.1	11.7	7.7	18.1	16.0	7.2	15.1	5.1	14.9	14.8	9.8	2.8	5.5	6.4	3.4	2.8	3.8	0.2	1.7	2.8	3.4	0.4	1.4	1.7	19.3	2.1	2.3	0.4	1.1	2.5	9.8	12.4	9.1	13.3	12.8	10.4	22.1	11.4	13.9	13.5
CYSRT1	"C9orf169, MGC59937"	ENSG00000197191	"Cysteine rich tail 1"		9	137224635-137226311	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	4	"esophagus: 33.4"	"Cell line enhanced"	"Detected in many"		"A-431: 9.8;CAPAN-2: 12.4;HaCaT: 13.8;HeLa: 12.2;MCF7: 19.1"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 23.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 3.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021883, HPA021886"	Approved		Approved	"Nuclear speckles,Vesicles,Midbody"				"Nuclear speckles"	"Vesicles, Midbody"	"HPA021883: AB_1853190, HPA021886: AB_1853192"	"unprognostic (1.35e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.31e-3)"	"unprognostic (6.87e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.11e-2)"	"unprognostic (5.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.29e-1)"	0.7	0.4	1.0	0.7	0.9	0.2	0.8	0.7	1.7	1.4	0.7	0.7	0.7	0.3	0.7	0.7	33.4	1.0	0.7	0.7	1.4	1.3	1.4	0.7	0.7	0.7	0.8	0.7	0.7	0.7	0.3	3.5	0.7	0.7	1.1	0.0	0.7	2.2	0.7	0.7	8.1	0.7	0.7	0.7	0.7	0.8	2.2	0.7	0.7	1.3	0.7	5.3	0.7	2.1	0.9	0.6	0.9	3.0	0.9	0.3	0.1	9.8	1.2	1.0	2.1	0.0	0.0	2.7	0.3	0.3	0.3	0.1	0.7	12.4	0.7	0.7	0.2	13.8	0.3	3.1	0.0	1.3	1.0	0.2	12.2	6.5	0.7	0.1	0.6	0.3	1.5	0.4	0.1	0.1	0.4	2.1	0.8	19.1	0.4	0.7	0.5	1.5	1.5	1.3	1.7	0.4	0.7	0.3	1.0	2.0	1.8	0.5	3.9	0.2	0.5	0.8	0.5	1.8	0.3	1.2	0.9	0.7	0.7	0.5	0.8	0.9	0.2	0.2	0.3	1.7	0.1	0.9	0.3	0.2	0.6	0.8	0.2	0.3	0.7	0.9	3.0	0.4	0.2	0.1	1.0	0.9	0.7	1.7	1.4	1.3	0.8	0.7	0.7	0.7
DNAAF1	"CILD13, FLJ25330, LRRC50, ODA7, swt"	ENSG00000154099	"Dynein axonemal assembly factor 1"	Q8NEP3	16	84145287-84178767	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.3;testis: 49.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 3.4;Karpas-707: 8.6;PC-3: 2.6;SK-BR-3: 2.4;U-266/70: 7.2;U-266/84: 4.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.1"	"Group enriched"	"Detected in many"	5	"amygdala: 3.5;basal ganglia: 9.4;hippocampal formation: 4.6;hypothalamus: 6.5;pons and medulla: 11.1"	"Cell type enhanced"	"Detected in some"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA041166, HPA074239"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nuclear speckles"	"HPA041166: AB_10794190, HPA074239: "	"unprognostic (5.25e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-2)"	"prognostic favourable (2.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-5)"	"unprognostic (2.70e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-4)"	"unprognostic (7.51e-4)"	0.8	1.2	3.5	0.6	9.4	1.5	0.5	0.1	1.5	2.1	0.6	5.3	1.5	0.4	1.0	13.3	0.9	21.3	0.5	0.4	4.6	6.5	0.7	2.0	3.7	0.9	0.5	1.5	4.2	0.4	0.7	6.1	1.5	11.1	0.4	0.4	0.9	0.5	0.6	0.6	0.5	0.6	0.4	1.0	7.2	0.5	49.6	1.2	0.0	1.2	0.0	0.4	0.8	0.0	0.5	1.0	5.5	0.8	0.9	2.1	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	3.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.3	0.0	0.1	1.3	0.2	0.0	0.0	2.4	0.1	0.9	0.0	0.0	0.4	0.0	0.0	0.0	7.2	4.7	0.7	0.2	0.4	0.0	3.6	0.8	0.4	0.4	0.6	0.1	0.0	0.2	0.1	0.4	0.5	0.8	0.8	5.5	0.9	0.4	1.0	2.1	0.9	3.5	9.4	0.1	1.5	4.6	6.5	0.5	1.5	11.1	1.2
E2F3		ENSG00000112242	"E2F transcription factor 3"	O00716	6	20401906-20493715	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029779, HPA065012"			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA029779: , HPA065012: "	"unprognostic (4.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.96e-1)"	"unprognostic (9.14e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-1)"	"prognostic favourable (1.69e-4)"	"unprognostic (1.14e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavourable (1.63e-8)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.99e-3)"	9.5	8.4	7.6	12.2	13.4	22.1	10.8	1.7	10.1	4.8	7.1	2.9	3.2	6.8	6.3	6.9	8.0	4.9	9.9	11.1	8.3	6.8	14.6	6.1	7.8	19.7	5.8	7.3	4.0	3.6	2.9	3.2	7.4	7.9	5.0	8.6	5.1	4.7	4.5	15.1	4.3	8.0	7.9	5.0	16.9	5.0	8.9	3.1	17.7	11.4	10.2	12.0	9.2	4.8	0.7	3.7	10.3	3.1	4.8	3.6	1.5	6.7	5.5	15.9	17.0	5.3	5.9	11.0	9.1	7.9	8.8	9.7	6.8	4.2	15.1	17.7	8.5	7.1	18.1	8.2	14.8	5.9	12.8	27.5	9.1	7.5	5.7	18.0	16.5	4.7	6.1	8.6	10.5	6.0	30.4	9.4	9.9	6.9	20.4	20.1	11.9	5.7	22.2	14.0	17.4	10.5	11.8	11.5	21.0	8.5	11.7	12.0	6.0	10.9	8.0	14.2	8.9	7.0	14.5	5.9	18.7	19.0	3.5	11.2	20.1	6.9	3.1	1.4	2.3	2.3	3.1	0.7	1.5	3.6	3.7	0.7	1.3	2.8	10.3	4.8	1.5	1.6	2.2	1.5	7.6	13.4	1.7	10.1	8.3	6.8	5.8	7.3	7.9	3.1
EEPD1	KIAA1706	ENSG00000122547	"Endonuclease/exonuclease/phosphatase family domain containing 1"	Q7L9B9	7	36153149-36301543	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.3;HDLM-2: 14.0;PC-3: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 23.2;neutrophil: 21.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 23.2;T-cells: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053668			Approved	"Nuclear speckles,Vesicles,Plasma membrane"				"Nuclear speckles"	"Vesicles, Plasma membrane"	"HPA053668: "	"unprognostic (1.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-3)"	"unprognostic (5.21e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.76e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.89e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.59e-2)"	20.3	5.1	4.9	6.4	8.6	8.1	22.5	3.3	19.3	9.6	15.2	11.8	6.5	11.0	12.5	5.6	6.5	5.4	18.4	6.2	6.4	5.4	3.7	15.2	8.7	4.6	13.3	3.5	6.9	8.1	2.4	3.3	4.6	5.6	8.2	4.5	5.7	3.8	4.3	39.7	10.2	23.6	9.1	10.2	7.5	10.5	3.4	7.7	11.5	2.2	4.4	3.6	6.1	10.9	0.1	1.5	23.2	2.8	1.7	11.5	2.0	1.6	4.6	1.4	4.5	13.3	2.9	0.1	1.1	5.7	0.9	1.6	0.9	3.5	4.5	1.5	1.7	1.9	1.9	2.2	0.8	14.0	3.2	0.6	0.4	8.4	1.2	0.7	4.4	5.9	1.4	0.5	0.4	0.1	5.5	0.5	1.0	1.8	4.6	11.2	6.5	17.8	1.2	1.6	1.0	2.8	3.7	3.5	2.5	0.4	0.6	1.7	1.4	5.4	0.4	1.8	5.3	1.2	1.3	3.5	3.8	0.0	4.4	3.0	1.1	10.0	2.8	23.2	1.5	1.7	2.6	0.1	11.5	3.3	1.5	0.0	2.6	0.7	21.9	1.7	0.7	1.3	5.1	2.0	4.9	8.6	3.3	7.5	6.4	5.4	13.3	3.5	5.6	7.7
EFCAB13	"C17orf57, FLJ40342"	ENSG00000178852	"EF-hand calcium binding domain 13"	Q8IY85	17	47323290-47441312	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"vagina: 29.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			"CAB002501, HPA021633, HPA023249, HPA026561"	Uncertain		Enhanced	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear speckles"	"CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596"	"unprognostic (1.66e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.79e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.46e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.90e-3)"	4.1	2.8	2.9	12.2	3.4	3.4	6.5	2.8	3.8	6.5	4.7	2.3	3.5	4.8	8.9	4.4	2.4	4.2	4.1	3.5	2.3	1.5	7.5	4.0	3.1	4.3	3.6	0.4	5.5	2.8	8.4	7.6	5.4	3.2	9.3	3.4	2.6	5.4	2.0	1.3	2.2	6.3	9.9	3.5	4.6	3.5	20.0	2.7	2.4	14.9	0.7	4.3	5.5	29.9	5.6	1.0	5.3	2.1	0.8	2.6	0.8	0.9	3.9	1.7	0.2	2.1	7.2	3.0	2.2	0.5	0.6	1.1	1.7	5.6	0.3	6.5	0.8	1.0	0.0	0.4	3.9	0.2	0.6	5.1	3.2	0.5	2.0	3.9	0.6	1.3	1.9	2.7	0.0	4.4	1.5	9.7	2.4	0.1	1.7	2.2	0.9	3.1	4.6	1.2	1.8	9.1	3.2	1.2	0.6	1.2	0.1	2.6	6.5	4.7	1.6	0.2	1.3	0.4	1.0	10.0	6.9	0.9	6.2	7.7	4.2	5.3	2.1	0.6	1.1	1.2	0.9	4.3	0.9	0.6	1.0	5.6	2.6	1.2	0.0	0.8	0.7	0.4	0.1	0.8	2.9	3.4	2.8	3.8	2.3	1.5	3.6	0.4	3.2	2.7
FOXJ3	KIAA1041	ENSG00000198815	"Forkhead box J3"	Q9UPW0	1	42176539-42335877	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067284			Approved	"Nucleoplasm,Nuclear speckles,Vesicles"				"Nucleoplasm, Nuclear speckles"	Vesicles	"HPA067284: "	"unprognostic (5.60e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.24e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (5.17e-6)"	"unprognostic (3.65e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.14e-2)"	"prognostic unfavourable (4.51e-7)"	"unprognostic (2.10e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-2)"	"unprognostic (5.43e-2)"	24.8	15.1	21.2	20.1	31.3	31.6	25.6	38.2	30.9	22.3	18.4	22.9	15.4	18.8	24.9	18.9	17.4	19.8	16.2	23.5	21.5	20.2	16.8	17.6	20.4	19.6	22.9	19.2	29.5	22.6	31.6	28.7	33.5	21.2	21.7	22.5	18.4	19.0	23.7	44.3	24.3	20.0	22.0	20.7	19.6	20.8	19.0	22.6	29.0	23.7	15.2	22.2	22.8	21.4	12.3	9.7	10.9	9.4	11.6	13.1	4.3	13.6	11.5	12.7	13.2	13.7	17.0	18.4	10.4	15.4	14.0	15.6	10.6	16.4	21.0	11.1	14.5	13.1	17.7	17.1	23.8	15.7	10.0	23.1	14.7	9.0	11.9	21.2	15.9	12.6	17.0	20.9	26.0	15.2	13.9	15.3	16.7	7.8	21.4	12.2	19.8	10.6	20.1	33.4	14.3	11.9	19.9	17.7	16.7	18.7	21.7	18.8	10.9	31.7	14.1	14.7	19.7	14.8	17.1	15.1	18.6	17.2	13.2	17.7	11.7	6.0	5.7	6.1	9.0	4.8	10.9	8.0	11.0	9.5	4.6	12.3	11.8	13.1	10.9	11.6	9.4	9.7	7.0	4.3	21.2	31.3	38.2	30.9	21.5	20.2	22.9	19.2	21.2	22.6
GCAT	KBL	ENSG00000100116	"Glycine C-acetyltransferase"	O75600	22	37807905-37817176	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 81.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA020460	Uncertain		Supported	"Nucleoplasm,Nuclear speckles,Mitochondria"				Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA020460: AB_1849548"	"unprognostic (1.61e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.73e-3)"	"unprognostic (3.99e-1)"	2.9	6.0	8.9	2.4	8.8	8.1	4.2	8.3	12.3	4.5	4.7	5.2	8.0	3.5	3.0	4.0	6.3	3.9	6.0	21.5	8.6	8.4	8.1	19.1	2.3	2.1	10.1	7.4	4.0	81.6	3.5	3.7	2.2	7.4	12.2	3.5	4.3	12.0	5.0	10.3	3.2	3.2	3.1	6.3	1.1	4.4	5.9	4.3	2.8	10.7	9.3	4.3	3.3	2.2	0.3	2.5	0.8	1.3	2.3	7.1	2.8	8.7	2.3	5.9	33.6	12.2	9.9	4.1	12.6	13.3	9.6	8.2	5.1	1.0	2.7	5.9	5.6	5.1	5.9	8.9	2.2	1.2	10.7	6.1	7.3	20.1	19.9	10.8	8.0	11.6	5.4	6.3	14.0	7.8	15.6	3.2	4.5	7.7	11.3	20.0	2.5	9.4	11.9	1.2	16.1	12.1	6.9	12.2	8.3	9.8	15.9	6.7	12.8	5.3	5.9	9.7	5.3	6.4	4.3	10.7	5.2	5.7	6.7	10.1	10.1	0.2	1.3	0.8	1.5	1.2	0.6	0.3	3.4	1.0	2.4	0.1	7.1	2.9	0.6	2.3	0.8	2.5	3.3	2.8	8.9	8.8	8.3	12.3	8.6	8.4	10.1	7.4	7.4	4.3
GNAQ	"G-ALPHA-q, GAQ"	ENSG00000156052	"G protein subunit alpha q"	P50148	9	77716087-78031458	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		Transducer	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 18.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010036, HPA048886"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Cytosol"			28000000	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB010036: AB_631536, HPA048886: "	"unprognostic (2.10e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-1)"	"prognostic favourable (1.11e-7)"	"unprognostic (1.90e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-1)"	12.7	12.6	24.3	9.9	20.8	21.8	11.6	12.5	29.6	13.1	16.6	17.1	9.1	7.9	13.7	11.2	13.1	10.0	11.6	5.6	24.2	18.3	12.1	12.3	23.1	11.8	19.1	14.6	13.5	8.5	12.7	7.6	12.1	14.3	13.0	16.0	10.4	9.8	15.9	5.9	5.1	9.0	18.2	23.9	5.8	15.5	6.0	14.8	18.6	13.3	4.0	4.8	14.5	13.1	0.8	2.8	18.4	3.5	3.3	2.0	1.2	12.1	13.9	12.3	13.5	15.6	16.0	17.8	16.5	12.5	7.3	8.8	4.2	10.0	0.0	13.4	15.1	20.0	9.1	10.0	9.1	0.4	5.3	33.3	12.1	8.5	14.1	20.3	12.5	10.9	12.3	14.1	14.4	17.8	5.8	0.1	12.8	15.4	23.4	12.9	10.0	2.0	8.7	15.1	0.1	16.5	26.1	13.8	21.1	11.9	10.1	12.4	9.1	7.6	22.3	12.8	0.8	17.4	9.6	0.1	0.0	0.1	8.8	12.0	13.2	18.4	2.2	4.6	0.8	1.9	1.6	0.8	1.8	1.0	2.4	0.8	2.0	1.6	7.7	3.3	3.5	2.8	1.9	1.2	24.3	20.8	12.5	24.0	24.2	18.3	19.1	14.6	14.3	14.8
GNB5	GB5	ENSG00000069966	"G protein subunit beta 5"	O14775	15	52115105-52191369	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032353, HPA041942, HPA044198"	Uncertain		Approved	"Nuclear speckles,Centrosome,Rods & Rings"			11000	"Nuclear speckles"	"Centrosome, Rods & Rings"	"CAB032353: AB_2263274, HPA041942: AB_10794309, HPA044198: "	"unprognostic (2.38e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.97e-3)"	"prognostic favourable (1.47e-6)"	"unprognostic (6.15e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.10e-1)"	"prognostic favourable (3.32e-11)"	"unprognostic (1.40e-3)"	"unprognostic (8.12e-3)"	"unprognostic (3.55e-3)"	"unprognostic (1.52e-1)"	6.2	11.2	17.7	8.2	25.6	3.7	8.9	42.5	30.7	15.2	9.2	4.0	9.6	4.6	21.2	13.4	9.0	20.4	15.4	17.3	13.0	18.6	26.9	10.3	5.8	14.7	13.6	21.9	38.1	13.7	35.5	14.7	4.4	21.3	12.9	4.5	20.4	6.5	20.3	1.7	4.8	7.0	13.3	5.9	8.3	7.5	11.7	9.2	7.0	16.2	1.9	14.1	14.6	14.0	21.6	9.9	3.6	1.9	10.8	19.7	9.3	8.0	20.8	5.8	10.2	9.9	12.4	5.6	15.8	15.4	14.1	15.4	5.8	6.1	14.1	5.0	12.9	11.9	10.2	15.0	10.7	10.9	7.7	9.4	28.1	6.7	11.8	4.7	34.1	11.4	12.7	11.3	4.2	8.8	0.7	13.3	15.4	14.4	7.4	13.4	5.3	9.2	10.0	20.1	17.1	10.0	24.7	9.3	8.1	15.1	1.4	12.3	4.9	14.7	21.6	12.7	13.9	14.4	15.9	8.5	16.3	15.4	26.7	11.5	20.4	3.6	1.9	0.2	10.7	1.7	8.9	21.0	14.0	12.8	4.8	21.6	13.2	11.3	1.0	10.8	1.4	9.9	19.7	9.3	17.7	25.6	42.5	30.7	13.0	18.6	13.6	21.9	21.3	9.2
GRAMD2A	GRAMD2	ENSG00000175318	"GRAM domain containing 2A"	Q8IUY3	15	72159807-72197785	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 24.6;placenta: 49.2"	"Group enriched"	"Detected in some"	12	"BEWO: 58.1;SK-BR-3: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"myeloid DC: 2.3"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 2.3"	"Low region specificity"	"Detected in many"							HPA029435	Uncertain		Approved	"Nucleoli,Nuclear speckles,Cytosol"				"Nucleoli, Nuclear speckles"	Cytosol	"HPA029435: AB_10601811"	"unprognostic (5.70e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.51e-3)"	"unprognostic (2.95e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (7.01e-4)"	"unprognostic (7.29e-2)"	0.1	0.0	2.0	0.2	4.5	0.0	6.8	1.1	1.0	3.1	0.7	1.2	9.8	0.6	0.4	24.6	1.0	8.2	0.8	0.1	2.9	6.5	1.9	0.1	9.7	0.2	1.1	0.1	1.1	1.0	0.2	0.9	49.2	3.9	1.2	0.5	1.0	1.8	4.0	0.3	1.5	3.6	0.1	1.0	0.1	0.4	0.7	0.9	0.2	7.7	1.3	1.1	0.3	0.6	0.0	2.3	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	26.5	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.5	1.1	1.0	2.9	6.5	1.1	0.1	3.9	0.9
GRK5	GPRK5	ENSG00000198873	"G protein-coupled receptor kinase 5"	P34947	10	119207589-119459742	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 36.5;HUVEC TERT2: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025579, HPA046838"	Approved		Supported	"Nuclear membrane,Nuclear speckles,Plasma membrane"				"Nuclear membrane, Nuclear speckles"	"Plasma membrane"	"CAB025579: , HPA046838: "	"unprognostic (1.09e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (2.38e-7)"	"unprognostic (1.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-2)"	15.9	8.3	3.4	16.8	7.8	2.7	10.2	6.5	5.0	12.5	18.8	3.9	4.5	12.4	13.4	12.2	8.1	7.7	19.5	45.4	4.2	4.2	4.3	5.7	27.6	8.8	3.7	2.5	16.5	3.5	26.2	6.3	24.0	4.5	7.5	6.4	5.6	5.0	6.7	12.8	4.7	10.4	10.8	4.8	17.0	13.9	3.5	4.7	9.8	8.9	10.7	8.6	9.5	13.6	9.3	2.2	6.5	3.7	0.2	11.3	4.2	4.0	2.3	6.0	6.1	13.8	13.3	1.8	7.8	36.5	4.9	2.7	1.9	5.9	4.3	1.8	12.2	1.0	2.6	8.6	3.2	17.1	2.1	0.7	5.0	7.7	9.5	0.2	2.2	1.8	1.3	9.8	1.4	28.8	0.4	4.2	1.7	0.6	4.0	3.9	0.9	6.0	1.4	0.8	1.0	0.8	1.6	2.0	5.5	2.7	1.2	7.5	0.1	1.0	8.7	2.6	1.9	15.8	3.0	0.9	4.6	2.6	5.5	4.8	2.5	0.9	3.7	6.5	5.3	3.2	0.4	9.3	7.7	3.8	2.2	9.1	11.3	5.0	5.0	0.2	0.9	0.0	9.2	4.2	3.4	7.8	6.5	5.0	4.2	4.2	3.7	2.5	4.5	4.7
HAUS6	"dgt6, FAM29A, FLJ20060, KIAA1574"	ENSG00000147874	"HAUS augmin like complex subunit 6"	Q7Z4H7	9	19053143-19103119	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 67.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020960, HPA020965"	Approved		Supported	"Nuclear speckles,Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"	"Nuclear speckles"	"HPA020960: AB_1848393, HPA020965: AB_1848394"	"unprognostic (1.58e-1)"	"unprognostic (9.85e-2)"	"unprognostic (6.04e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (3.84e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (3.13e-5)"	"unprognostic (2.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.03e-1)"	8.7	9.6	10.9	9.2	13.1	17.5	11.1	10.8	10.3	7.7	7.0	9.9	5.6	4.9	8.9	8.0	7.0	7.4	6.4	7.1	10.5	7.3	5.2	11.0	7.1	12.8	15.0	8.9	11.1	6.3	5.8	8.5	8.4	12.4	7.6	7.9	5.6	7.1	7.4	7.2	9.8	7.2	8.9	13.5	10.0	5.8	27.1	13.6	27.3	6.6	3.8	12.7	7.0	7.1	3.6	2.6	10.9	2.2	7.2	6.1	2.5	10.8	7.4	15.3	11.9	5.9	7.1	8.3	11.7	8.3	10.8	16.7	3.8	5.0	12.7	4.3	6.7	4.5	14.0	6.8	16.8	11.6	6.7	67.7	13.5	8.7	3.9	8.9	15.5	4.4	7.1	10.2	22.3	7.8	9.2	8.4	12.4	3.5	17.4	15.2	16.3	7.5	13.6	10.4	5.2	5.8	6.3	8.9	12.3	5.2	4.8	7.4	3.8	11.3	7.7	9.7	5.9	8.3	13.4	3.3	7.3	12.6	9.1	7.6	4.2	10.9	2.2	2.2	4.5	2.2	6.1	3.5	4.3	5.6	2.2	3.6	5.2	4.6	3.5	7.2	2.0	2.6	5.4	2.5	10.9	13.1	10.8	10.3	10.5	7.3	15.0	8.9	12.4	13.6
HDAC4	"BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288"	ENSG00000068024	"Histone deacetylase 4"	P56524	2	239048168-239401654	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Autism spectrum disorder, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 54.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 10.5;classical monocyte: 7.4;neutrophil: 28.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 28.3;monocytes: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004431, HPA048723"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nucleoplasm, Cytosol"	"CAB004431: AB_627706, HPA048723: "	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-3)"	"unprognostic (3.06e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (6.33e-4)"	"prognostic favourable (1.13e-4)"	"unprognostic (1.40e-1)"	"unprognostic (4.82e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.04e-2)"	7.9	6.8	6.1	6.8	5.2	17.1	4.6	6.4	12.3	11.3	21.4	4.6	4.3	2.5	10.2	6.4	8.8	9.0	24.6	5.2	5.0	6.0	3.2	3.1	4.2	4.3	6.1	5.4	8.5	5.8	4.9	8.3	2.5	5.2	7.5	4.8	8.3	3.7	7.3	54.6	6.9	6.5	15.8	4.2	5.4	7.0	8.1	4.3	6.5	4.8	13.2	5.6	10.2	4.6	0.5	1.7	28.3	7.4	2.1	1.2	0.4	4.3	4.3	5.5	6.6	3.1	5.3	6.5	4.5	3.1	3.6	3.4	2.0	7.8	2.0	1.8	3.9	4.3	3.8	1.8	1.8	12.0	2.0	3.2	5.3	6.3	4.2	4.9	2.9	3.6	4.6	6.6	5.3	3.8	4.5	4.6	1.7	5.3	31.6	6.7	4.3	2.2	8.2	10.4	3.2	4.1	5.5	4.4	7.8	6.3	2.8	11.1	1.5	13.4	6.1	4.2	0.3	7.2	6.1	3.3	3.1	3.9	6.1	6.8	8.3	10.5	7.4	1.1	0.9	2.4	1.1	0.5	0.9	0.8	0.8	0.5	0.5	1.0	28.3	2.1	1.0	1.7	1.2	0.4	6.1	5.2	6.4	7.5	5.0	6.0	6.1	5.4	5.2	4.3
HDAC5	"FLJ90614, KIAA0600, NY-CO-9"	ENSG00000108840	"Histone deacetylase 5"	Q9UQL6	17	44076746-44123702	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019400, HPA030991"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Cytosol"				"Nuclear speckles"	"Golgi apparatus, Cytosol"	"CAB019400: AB_2116626, HPA030991: AB_10795286"	"unprognostic (1.30e-2)"	"prognostic favourable (6.14e-4)"	"unprognostic (6.65e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (3.12e-5)"	"unprognostic (8.80e-3)"	"unprognostic (3.80e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (4.30e-1)"	"prognostic favourable (3.30e-5)"	"unprognostic (1.51e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.76e-2)"	15.6	17.6	24.9	7.9	15.8	13.2	18.1	35.9	25.8	16.5	8.8	19.6	9.5	8.4	15.0	11.9	20.1	16.9	11.3	24.4	22.1	24.2	8.6	6.3	13.6	8.8	24.7	22.1	24.5	16.1	28.2	17.5	23.0	19.3	13.6	5.5	11.7	14.2	11.9	42.6	34.0	9.7	12.4	20.5	13.8	9.3	10.3	18.1	7.6	15.0	9.8	8.2	14.9	20.4	7.6	9.4	17.9	13.6	3.5	4.9	5.0	3.5	2.3	6.4	1.5	12.4	9.7	23.1	9.6	24.0	4.8	7.9	5.1	3.8	5.6	3.9	22.8	2.9	7.5	4.1	2.0	8.7	12.2	10.9	7.7	11.7	5.3	3.5	15.4	13.7	7.1	5.5	6.9	3.9	8.1	11.4	27.8	2.7	5.8	10.7	7.0	5.5	22.5	17.9	14.4	0.5	1.6	16.7	8.8	2.8	11.8	13.0	16.8	20.7	2.1	12.1	7.8	2.8	4.8	18.8	15.7	6.7	7.0	4.4	5.7	7.1	7.3	7.7	4.9	11.6	3.5	6.6	3.9	4.9	9.4	7.6	4.1	3.5	17.9	3.5	13.6	8.3	3.5	5.0	24.9	15.8	35.9	25.8	22.1	24.2	24.7	22.1	19.3	18.1
HES5	bHLHb38	ENSG00000197921	"Hes family bHLH transcription factor 5"	Q5TA89	1	2528745-2530245	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 16.7"	"Cell line enhanced"	"Detected in some"		"AF22: 2.6;HaCaT: 5.0;HAP1: 1.1;SCLC-21H: 1.0"	"Cancer enhanced"	"Detected in some"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA065458, HPA076164"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA065458: , HPA076164: "	"unprognostic (2.04e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.60e-4)"	"unprognostic (1.76e-4)"	"unprognostic (1.60e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.67e-1)"	"unprognostic (9.95e-4)"	"unprognostic (1.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.72e-1)"	1.1	0.9	11.1	1.1	12.7	1.4	2.8	3.5	16.7	1.0	1.9	1.2	0.4	1.2	1.9	2.7	1.6	1.1	1.2	2.3	9.7	11.2	1.0	1.0	1.4	1.1	4.1	15.8	1.0	0.9	1.0	2.4	2.2	1.6	1.3	1.4	6.3	1.2	1.1	1.6	6.2	1.2	0.9	0.9	1.0	1.2	2.0	1.9	0.0	1.1	1.9	1.4	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	5.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	12.7	3.5	16.7	9.7	11.2	4.1	15.8	1.6	1.9
HIKESHI	"C11orf73, HSPC138, HSPC179, OPI10"	ENSG00000149196	"Hikeshi, heat shock protein nuclear import factor"	Q53FT3	11	86302211-86345931	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012708, HPA035063, HPA035064"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Nuclear bodies"				"Nuclear speckles"	"Nucleoplasm, Nuclear bodies"	"HPA012708: , HPA035063: AB_10601143, HPA035064: "	"unprognostic (1.10e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.18e-1)"	"prognostic unfavourable (8.81e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavourable (4.01e-12)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.71e-1)"	23.4	24.1	25.7	16.0	23.3	15.5	31.1	19.1	24.0	21.1	23.5	20.1	14.5	10.2	27.4	24.9	24.6	18.2	15.5	36.1	23.9	23.8	11.7	20.0	16.9	22.0	30.2	18.9	26.2	22.6	18.7	32.0	26.6	25.9	18.1	19.2	15.7	15.4	29.2	46.9	20.2	13.0	30.0	25.1	18.1	15.9	15.3	26.6	23.8	20.8	23.6	28.1	21.6	24.0	30.0	33.3	20.6	26.7	25.9	39.5	20.7	9.8	10.6	26.0	14.3	22.0	27.5	13.7	15.2	18.4	15.9	19.0	31.6	27.4	10.0	35.1	20.0	21.1	19.2	33.4	17.0	21.3	16.9	16.1	17.6	23.4	29.7	19.7	13.2	19.3	34.0	19.0	22.6	30.4	17.3	23.0	32.4	26.8	23.5	46.9	21.2	7.2	18.1	12.8	22.4	27.2	18.6	16.1	13.9	18.9	14.2	10.3	22.7	13.3	15.4	18.9	13.3	37.8	11.2	9.9	22.4	19.3	9.6	18.7	18.5	19.6	26.7	20.6	25.2	24.7	27.7	30.0	30.9	27.3	33.3	24.9	27.2	27.6	5.5	25.9	24.3	25.9	39.5	20.7	25.7	23.3	19.1	24.0	23.9	23.8	30.2	18.9	25.9	26.6
HTR7	5-HT7	ENSG00000148680	"5-hydroxytryptamine receptor 7"	P34969	10	90740823-90857698	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 30.8;testis: 14.3"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 8.1;hTCEpi: 7.3;hTERT-HME1: 24.5;LHCN-M2: 9.8;U-87 MG: 7.5;WM-115: 9.3"	"Group enriched"	"Detected in some"	5	"cervical cancer: 0.9;head and neck cancer: 3.3;lung cancer: 0.9;urothelial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"myeloid DC: 4.6"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022708, HPA073617"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"				"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB022708: , HPA073617: "	"unprognostic (1.17e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.84e-2)"	"unprognostic (6.49e-2)"	1.0	0.5	2.4	1.1	2.5	0.5	0.7	0.3	4.3	0.6	0.8	1.7	1.2	0.8	0.4	0.3	1.0	0.4	1.3	0.6	9.9	5.1	0.3	0.6	0.5	0.7	1.7	1.8	0.4	1.4	30.8	0.2	0.5	3.1	1.0	1.2	0.4	0.6	0.3	1.7	0.9	2.2	3.6	1.5	1.3	1.5	14.3	1.0	0.0	0.3	0.1	0.6	3.5	2.1	0.0	4.6	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.2	0.5	0.7	0.0	0.9	0.0	0.0	0.1	3.3	0.9	8.1	2.0	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.4	5.8	7.3	2.4	24.5	0.0	0.0	0.0	9.8	0.0	0.0	0.1	0.9	1.2	0.7	0.1	0.0	0.0	0.9	0.3	0.0	0.3	0.0	3.8	0.0	0.2	0.2	4.5	0.0	0.0	6.8	0.0	0.0	0.0	7.5	0.0	9.3	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	4.6	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.1	0.1	2.4	2.5	0.3	4.3	9.9	5.1	1.7	1.8	3.1	1.0
IFT57	"ESRRBL1, FLJ10147, HIPPI, MHS4R2"	ENSG00000114446	"Intraflagellar transport 57"	Q9NWB7	3	108160812-108222570	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	DNA-binding	Ciliopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 22.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035514, HPA035515"	Supported		Approved	"Nuclear speckles,Mitochondria,Cytosol"				"Nuclear speckles"	"Mitochondria, Cytosol"	"HPA035514: AB_10601757, HPA035515: AB_10696505"	"unprognostic (1.35e-2)"	"unprognostic (1.37e-2)"	"prognostic favourable (6.96e-5)"	"unprognostic (2.98e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.59e-2)"	"prognostic favourable (7.63e-4)"	"unprognostic (5.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.12e-2)"	8.5	13.1	9.4	12.1	11.0	8.8	10.4	5.5	16.4	13.3	10.9	6.3	15.7	5.0	11.8	36.3	11.6	24.8	11.6	12.1	9.2	11.2	19.7	3.7	34.3	12.2	9.1	9.9	21.6	13.4	16.4	30.6	6.2	13.5	21.9	11.6	9.4	8.2	16.0	5.7	7.1	9.4	13.1	6.2	14.3	10.0	38.6	5.6	8.3	31.3	7.4	12.2	14.1	9.1	22.4	5.8	1.8	6.7	3.6	4.7	2.9	18.6	9.7	7.0	12.5	14.7	15.2	3.9	5.7	14.0	8.5	7.6	6.6	3.3	21.1	7.4	9.5	7.5	6.2	9.5	14.5	3.3	6.7	7.2	4.3	1.7	11.0	14.9	16.7	9.2	8.9	10.9	19.0	9.5	3.3	3.8	9.6	10.4	4.9	13.7	7.5	11.5	3.2	6.3	3.6	17.4	6.8	11.6	8.1	8.6	2.8	5.2	6.1	4.6	4.0	10.9	5.6	5.7	6.7	4.5	3.2	11.1	15.8	1.5	4.0	0.1	2.1	1.8	2.2	3.6	3.6	22.4	4.7	2.8	5.8	18.6	4.1	2.3	1.1	3.6	6.7	1.2	2.9	2.9	9.4	11.0	5.5	16.4	9.2	11.2	9.1	9.9	13.5	5.6
IQUB	FLJ35834	ENSG00000164675	"IQ motif and ubiquitin domain containing"	Q8NA54	7	123452400-123535077	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 20.8;testis: 35.5"	"Cell line enhanced"	"Detected in some"		"K-562: 1.8;RPTEC TERT1: 7.1;T-47d: 2.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049626			Approved	"Nuclear speckles,Intermediate filaments,Cytosol"				"Nuclear speckles, Intermediate filaments"	Cytosol	"HPA049626: "	"unprognostic (8.71e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.42e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.44e-6)"	"unprognostic (2.79e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.30e-2)"	0.6	1.0	1.3	0.3	2.9	0.3	0.9	3.0	3.5	1.2	0.5	1.8	3.2	0.4	1.4	6.9	1.8	5.7	1.6	0.6	2.6	1.2	8.5	0.4	3.2	0.3	0.7	1.2	2.7	0.7	2.7	20.8	0.5	6.4	0.9	0.4	0.3	0.7	4.3	0.6	0.5	0.5	0.6	1.0	0.4	0.6	35.5	2.8	0.0	5.6	0.0	0.3	0.7	0.6	0.8	0.0	0.0	0.3	0.5	0.7	0.0	0.3	0.0	1.3	0.6	0.6	0.6	0.1	0.0	0.1	0.0	0.3	0.0	0.8	0.8	0.0	0.4	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.7	0.3	0.2	0.3	0.0	1.8	0.2	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.1	1.6	1.1	0.4	0.0	0.0	0.1	2.5	0.0	0.0	0.5	0.3	0.4	0.2	0.4	0.1	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.7	0.3	0.4	0.2	0.2	0.2	0.0	0.8	0.7	0.2	0.0	0.5	0.1	0.0	0.3	0.0	1.3	2.9	3.0	3.5	2.6	1.2	0.7	1.2	6.4	2.8
IRX5	IRX-2a	ENSG00000176842	"Iroquois homeobox 5"	P78411	16	54930862-54934485	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Vision"	DNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 19.0;heart muscle: 26.5"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 17.8;T-47d: 24.3;THP-1: 13.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 20.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"cerebellum: 4.1;hypothalamus: 3.2;midbrain: 7.6;pons and medulla: 5.7;thalamus: 4.7"	HPA047130			Approved	"Nuclear speckles,Microtubules,Cytosol"				"Nuclear speckles"	"Microtubules, Cytosol"	"HPA047130: AB_10962983"	"unprognostic (2.63e-1)"	"unprognostic (4.49e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.38e-3)"	"prognostic favourable (4.59e-4)"	"unprognostic (8.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.34e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.77e-3)"	"unprognostic (4.28e-2)"	3.3	0.7	0.2	0.2	1.4	0.2	19.0	5.8	0.3	3.6	0.5	1.7	0.2	0.2	0.4	1.9	7.6	0.3	0.4	26.5	0.9	1.3	4.7	0.2	10.3	0.3	2.6	0.0	0.5	0.3	0.5	0.3	0.2	5.3	4.2	0.2	6.5	13.6	0.5	6.7	13.9	0.2	0.3	4.5	0.2	3.3	0.9	2.2	0.4	0.2	1.0	2.4	0.8	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	5.7	2.1	2.1	0.4	0.2	2.2	5.4	0.7	0.5	1.2	0.5	0.0	0.5	2.9	5.5	2.0	2.3	0.4	3.8	2.7	0.6	2.3	0.0	0.0	1.3	2.2	0.6	10.1	3.6	1.5	0.0	0.3	0.0	4.1	2.0	6.0	7.8	0.1	1.6	3.2	2.9	0.3	17.8	0.1	2.0	2.0	0.9	4.9	2.4	24.3	13.0	0.3	4.0	0.1	2.8	0.8	2.4	1.4	1.8	6.4	2.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	5.8	0.2	0.9	1.3	2.6	0.0	5.3	2.2
ITGA7		ENSG00000135424	"Integrin subunit alpha 7"	Q13683	12	55684568-55716043	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Cell shape"	"Integrin, Receptor"	"Congenital muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 66.4;skeletal muscle: 81.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 29.5;hTEC/SVTERT24-B: 27.9;LHCN-M2: 16.9;SK-MEL-30: 20.4;U-87 MG: 25.2"	"Cancer enhanced"	"Detected in all"		"glioma: 35.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008427	Uncertain		Approved	"Nuclear speckles,Vesicles,Plasma membrane"			770000	"Plasma membrane"	"Nuclear speckles, Vesicles"	"HPA008427: AB_1851823"	"unprognostic (4.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.02e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.57e-1)"	"prognostic favourable (1.75e-4)"	"unprognostic (2.85e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (9.59e-5)"	46.2	3.4	6.1	7.2	6.8	0.9	20.6	3.6	7.6	6.3	22.4	5.7	5.9	6.6	15.1	13.5	11.6	12.9	14.8	66.4	7.8	2.6	3.1	4.1	3.4	2.9	3.9	7.6	5.1	1.9	3.4	3.1	1.0	5.7	8.9	3.7	5.6	3.3	14.6	81.3	3.6	7.2	33.3	4.5	2.4	10.3	2.9	5.3	0.2	6.5	10.6	2.2	13.6	14.1	0.5	1.7	0.0	1.0	0.0	0.8	0.3	0.1	1.7	3.2	5.2	29.5	5.9	0.3	2.2	3.7	5.0	5.2	3.5	2.8	0.9	3.2	1.4	0.4	2.2	0.1	4.5	0.1	1.6	0.3	1.1	1.3	0.2	0.1	1.1	8.3	0.0	27.9	0.1	0.0	0.4	0.6	16.9	2.1	0.1	1.2	9.0	0.2	0.0	12.2	0.2	0.1	0.0	0.4	1.2	0.2	0.0	20.4	0.3	5.7	0.0	0.5	5.5	0.3	3.5	1.3	0.9	0.3	25.2	3.4	0.3	0.0	0.7	0.0	0.4	1.0	0.0	0.1	0.0	0.8	1.7	0.5	0.3	0.4	0.0	0.0	1.0	0.6	0.0	0.3	6.1	6.8	3.6	7.6	7.8	2.6	3.9	7.6	5.7	5.3
KAT6A	"MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220"	ENSG00000083168	"Lysine acetyltransferase 6A"	Q92794	8	41929479-42051990	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase"	"Cancer-related genes, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017023, HPA063266, HPA065052"	Supported		Approved	"Nucleoli,Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nucleoli, Cytosol"	"CAB017023: , HPA063266: , HPA065052: "	"unprognostic (3.51e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.27e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	20.8	10.9	15.3	19.8	20.3	36.8	22.6	29.9	18.7	19.7	14.6	19.4	14.4	10.7	20.6	12.1	16.9	16.5	14.3	13.0	15.5	11.5	12.3	13.6	26.9	28.2	23.2	10.3	27.2	13.1	26.8	22.3	20.9	15.7	14.1	12.0	12.8	15.1	17.0	21.0	25.5	18.0	25.0	22.9	20.4	14.0	14.1	21.7	30.4	17.9	14.3	20.1	16.9	24.2	4.7	1.8	10.9	1.6	3.1	3.9	1.4	12.9	10.6	17.5	11.1	9.8	11.2	5.9	8.7	11.3	10.8	8.4	6.7	6.2	19.2	8.7	8.5	8.3	13.6	8.2	12.7	9.9	7.9	27.6	6.6	5.0	7.4	14.5	12.7	9.3	9.4	10.0	12.4	10.3	23.1	12.2	9.8	5.7	29.5	4.6	6.7	4.2	23.6	19.6	6.1	5.3	14.9	10.9	9.4	10.1	6.8	7.0	15.6	6.4	12.0	13.3	9.4	11.8	9.3	10.0	16.1	20.8	7.1	6.6	11.5	3.5	1.6	2.8	3.5	1.2	3.9	2.4	2.6	3.3	1.0	4.7	3.6	2.9	10.9	3.1	1.2	1.8	3.5	1.4	15.3	20.3	29.9	18.7	15.5	11.5	23.2	10.3	15.7	21.7
KAZN	"FLJ43806, KAZRIN, KIAA1026"	ENSG00000189337	"Kazrin, periplakin interacting protein"	Q674X7	1	13892792-15118043	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 64.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 39.7;SK-BR-3: 21.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 6.9"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 6.9"									"HPA032095, HPA032096"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA032095: , HPA032096: AB_10670826"	"unprognostic (2.81e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-3)"	"unprognostic (5.34e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.57e-3)"	"unprognostic (7.88e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.55e-2)"	"prognostic favourable (1.20e-6)"	"unprognostic (3.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.06e-2)"	8.0	11.0	13.4	3.0	17.4	1.2	7.6	41.1	21.9	8.0	3.8	27.5	5.7	4.6	3.1	11.1	18.8	11.0	7.0	4.1	12.4	12.4	13.2	5.2	8.5	1.5	25.1	12.1	10.4	8.0	22.9	2.7	11.0	15.0	4.1	4.0	10.5	16.8	7.2	1.7	14.2	4.9	3.7	25.0	64.9	4.9	4.1	18.9	0.0	6.6	7.0	6.3	7.9	9.4	0.3	0.0	6.9	0.0	0.0	0.0	0.0	7.8	1.4	8.6	39.7	3.8	3.9	2.9	3.8	3.2	7.1	5.1	1.8	4.2	0.0	9.9	8.1	2.8	1.9	6.2	3.5	0.2	3.9	4.5	4.7	11.8	2.8	0.0	2.3	5.5	8.3	1.6	1.1	0.0	1.8	9.2	5.6	5.7	0.0	0.4	2.4	1.2	2.7	0.2	4.8	11.9	2.4	4.6	3.3	0.6	21.6	14.8	1.2	3.0	0.0	5.8	5.5	9.2	4.5	1.5	1.3	0.0	5.4	7.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	13.4	17.4	41.1	21.4	12.4	12.4	25.1	12.1	15.0	18.9
KIAA1328		ENSG00000150477	KIAA1328	Q86T90	18	36829106-37232172	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040946	Approved		Approved	"Nuclear speckles,Vesicles,Lipid droplets"				"Nuclear speckles"	"Vesicles, Lipid droplets"	"HPA040946: AB_10794998"	"unprognostic (3.66e-2)"	"unprognostic (5.37e-4)"	"unprognostic (2.76e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.99e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.06e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.64e-3)"	11.1	8.1	14.0	10.7	14.3	23.1	11.1	27.4	13.0	13.7	7.5	13.0	6.1	9.2	12.6	11.1	7.9	9.4	8.3	9.8	10.7	8.5	9.2	7.7	10.4	8.5	12.3	9.0	18.3	6.9	9.0	18.6	9.7	10.3	11.1	7.4	10.9	10.9	9.5	11.4	15.7	9.7	15.8	13.2	8.9	10.7	19.6	14.4	5.4	11.1	9.7	11.5	10.1	11.0	12.7	5.7	17.1	7.4	7.5	10.4	3.6	14.5	4.4	6.5	7.9	2.3	3.1	6.3	5.6	2.1	2.6	1.9	7.7	9.7	9.5	21.1	2.1	6.5	2.6	2.7	3.4	7.4	2.7	12.4	12.0	4.8	1.8	7.9	6.0	3.2	3.0	3.1	2.7	2.3	9.8	23.7	2.6	14.3	5.5	6.0	14.9	7.7	7.9	6.8	7.0	2.5	14.8	7.1	8.2	7.6	9.2	3.7	14.8	4.5	8.0	13.0	19.0	7.5	6.7	18.8	24.0	7.5	6.6	5.7	8.5	17.1	6.8	9.2	9.0	4.8	10.4	7.5	8.0	7.4	3.1	12.7	10.1	8.4	15.1	7.5	7.4	5.7	8.9	3.6	14.0	14.3	27.4	13.0	10.7	8.5	12.3	9.0	10.3	14.4
LNP1	NP3	ENSG00000206535	"Leukemia NUP98 fusion partner 1"	A1A4G5	3	100401193-100456319	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 31.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 9.4;cerebral cortex: 11.0;hippocampal formation: 10.1;olfactory region: 9.4"	HPA047926			Approved	"Nuclear speckles,Vesicles,Cytosol"				Vesicles	"Nuclear speckles, Cytosol"	"HPA047926: "	"unprognostic (1.78e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.40e-3)"	"unprognostic (6.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.08e-2)"	3.1	2.8	6.5	1.7	11.4	0.6	2.7	7.9	9.7	3.4	2.3	1.5	3.4	1.2	4.6	8.4	1.9	4.0	2.7	9.5	5.3	7.2	4.8	7.4	3.8	1.4	5.7	5.6	6.3	4.5	3.0	17.0	3.7	7.4	2.8	2.2	9.0	2.4	3.3	4.3	1.0	1.5	4.5	4.2	1.8	1.9	31.9	3.5	1.6	5.3	0.8	1.7	3.1	1.8	0.9	0.2	0.0	0.4	0.2	2.7	0.8	2.8	1.6	8.3	1.2	5.4	2.3	0.7	2.2	5.5	1.8	2.2	0.6	0.7	2.5	1.0	1.6	1.8	2.2	1.9	2.2	2.6	2.3	6.1	0.8	2.8	1.6	3.5	0.7	2.5	0.7	1.0	4.7	0.4	2.3	9.5	1.6	2.1	4.9	3.5	5.7	12.5	3.8	4.6	5.0	1.7	0.3	8.6	4.3	1.6	2.4	3.4	0.6	0.4	0.6	0.9	8.9	0.8	2.0	11.2	11.9	7.3	2.5	3.0	1.5	0.0	0.4	0.0	1.1	0.2	2.5	0.9	1.1	0.6	0.2	0.9	1.0	1.1	0.0	0.2	0.0	0.0	2.7	0.8	6.5	11.4	7.9	9.7	5.3	7.2	5.7	5.6	7.4	3.5
LPXN	LDPL	ENSG00000110031	Leupaxin	O60711	11	58526871-58578220	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 42.0;lymphoid tissue: 75.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 39.3;HMC-1: 65.8;Karpas-707: 56.4;U-2197: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043741, CAB046478, HPA061441"	Enhanced		Supported	"Nuclear speckles,Focal adhesion sites,Cytosol"				"Focal adhesion sites"	"Nuclear speckles, Cytosol"	"CAB046478: AB_10603113, HPA043741: AB_2678647, HPA061441: AB_2684518"	"unprognostic (1.61e-3)"	"unprognostic (6.91e-2)"	"unprognostic (6.54e-2)"	"prognostic favourable (8.81e-4)"	"unprognostic (5.16e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.41e-3)"	16.3	5.6	5.1	34.2	4.7	4.2	5.1	3.5	4.9	4.4	6.7	9.0	4.1	5.1	6.5	5.9	3.8	4.7	7.2	3.9	5.2	5.1	6.3	7.1	19.7	37.2	6.3	2.5	6.6	5.6	3.9	4.8	2.6	5.0	5.7	9.6	6.2	7.6	5.1	2.1	3.7	16.0	4.7	11.4	32.2	5.7	5.9	4.9	75.1	6.8	4.4	52.9	11.2	3.9	19.9	36.5	3.8	19.1	20.1	42.0	20.9	0.3	0.4	0.4	0.7	1.5	1.9	0.2	9.8	39.3	2.4	4.4	0.0	1.0	28.7	0.4	11.9	0.3	0.3	26.7	10.3	12.4	0.1	1.3	0.2	0.1	2.6	7.7	65.8	1.4	0.6	33.9	4.4	15.8	0.3	56.4	19.9	0.2	27.1	9.7	0.3	8.9	0.4	0.5	24.7	1.6	13.7	0.2	0.3	0.4	0.6	3.9	0.5	2.2	15.4	6.2	1.8	39.6	8.8	3.6	3.5	28.2	14.3	7.0	14.0	1.7	19.1	3.1	28.2	11.0	42.0	19.9	29.0	32.4	36.5	11.5	22.6	26.8	3.8	20.1	5.6	33.1	38.7	20.9	5.1	4.7	3.5	4.9	5.2	5.1	6.3	2.5	5.0	4.9
MAP3K7	"MEKK7, TAK1"	ENSG00000135341	"Mitogen-activated protein kinase kinase kinase 7"	O43318	6	90513573-90587045	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007633, HPA075335"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"				Cytosol	"Nuclear speckles, Plasma membrane"	"HPA007633: AB_1079359, HPA075335: "	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (3.51e-4)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.17e-1)"	15.5	17.6	19.6	17.3	26.3	10.3	21.6	27.5	27.3	21.1	16.4	15.7	15.8	12.5	23.1	23.6	15.2	15.5	17.6	22.2	20.5	17.5	15.9	15.5	20.0	22.2	22.9	16.4	25.0	13.5	25.8	25.6	23.6	20.7	21.2	15.3	12.4	17.0	23.3	24.3	18.7	14.7	19.4	23.0	23.3	14.7	13.8	21.7	28.2	20.3	10.8	21.9	17.2	18.9	14.2	15.9	19.4	17.7	18.2	22.1	13.6	7.7	6.9	20.1	17.2	14.7	19.7	14.2	15.6	18.1	14.1	17.8	8.8	7.5	17.3	10.0	16.9	8.3	12.6	12.2	24.0	8.8	13.4	15.4	9.5	11.7	15.4	17.1	11.9	16.2	14.9	13.7	16.9	13.2	30.8	14.2	20.1	9.5	7.9	14.5	16.5	8.7	13.7	36.1	8.4	11.8	8.7	10.2	14.5	10.9	7.6	11.8	7.5	30.5	12.6	11.5	7.3	10.5	14.5	12.7	11.3	7.5	17.6	18.8	16.8	15.5	12.7	19.4	15.1	17.4	16.8	14.2	14.5	14.4	15.9	10.5	16.5	16.0	12.5	18.2	17.7	9.8	22.1	13.6	19.6	26.3	27.5	27.3	20.5	17.5	22.9	16.4	20.7	21.7
NONO	"NMT55, NRB54, P54, P54NRB, PPP1R114"	ENSG00000147140	"Non-POU domain containing octamer binding"	Q15233	X	71283192-71301168	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022069, HPA054094, HPA054559"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles"			150000	Nucleoplasm	"Nucleoli fibrillar center, Nuclear speckles"	"CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522"	"unprognostic (2.39e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavourable (9.29e-4)"	"unprognostic (8.87e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.02e-3)"	"unprognostic (9.34e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.29e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.73e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.04e-2)"	37.2	55.9	30.2	37.7	30.8	51.2	37.2	54.8	38.6	45.4	33.4	36.0	38.4	29.9	52.4	40.5	41.0	40.5	37.2	30.5	27.5	29.0	40.1	43.3	37.3	45.7	28.8	31.7	69.2	61.0	39.4	48.2	42.4	27.5	40.8	37.5	42.5	39.8	41.4	37.2	38.4	35.2	40.5	38.3	45.9	40.3	34.4	29.0	98.4	51.0	39.1	57.4	43.6	36.8	44.1	47.3	35.3	51.8	45.4	51.8	58.9	58.5	64.8	89.7	49.2	36.6	37.8	49.1	48.0	44.7	65.0	57.4	51.4	43.5	66.6	53.5	44.2	43.8	133.8	41.7	71.6	50.7	89.4	54.6	68.0	51.1	31.0	76.6	48.0	40.0	29.8	65.7	44.1	53.3	69.6	69.9	59.9	52.0	99.0	69.8	111.6	52.6	89.1	94.0	57.1	49.8	51.8	62.3	77.3	62.2	40.6	55.1	38.2	49.6	48.9	42.1	63.2	58.8	55.5	40.3	76.3	75.8	31.4	89.1	60.1	35.3	44.8	34.9	45.8	47.6	51.8	43.7	46.6	44.9	47.3	44.1	50.8	50.2	20.8	45.4	51.8	41.2	50.1	58.9	30.2	30.8	54.8	38.6	27.5	29.0	28.8	31.7	27.5	29.0
NR0B1	"AHC, AHCH, DAX1, DSS"	ENSG00000169297	"Nuclear receptor subfamily 0 group B member 1"	P51843	X	30304206-30309598	"Cancer-related genes, Disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Receptor, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adrenal gland: 23.9;testis: 36.0"	"Group enriched"	"Detected in some"	4	"A549: 34.3;RT4: 10.8"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA061948, HPA067207"			Supported	"Nuclear speckles,Vesicles,Centriolar satellite"				"Nuclear speckles"	"Vesicles, Centriolar satellite"	"HPA061948: , HPA067207: "		"unprognostic (1.50e-2)"			"unprognostic (9.68e-2)"			"unprognostic (9.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.45e-3)"		"unprognostic (4.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.33e-3)"			0.4	23.9	1.0	0.0	0.8	0.0	0.2	0.4	1.1	1.3	0.1	1.7	0.0	0.0	0.4	0.9	0.1	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.1	0.0	0.5	0.6	3.5	2.1	0.0	1.6	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.6	0.1	0.7	36.0	0.7	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.9	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	5.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.4	1.1	0.9	0.9	0.5	0.6	0.6	0.7
PCDHA5	"CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5"	ENSG00000204965	"Protocadherin alpha 5"	Q9Y5H7	5	140821604-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"brain: 13.6"	"Cell line enhanced"	"Detected in some"		"A549: 2.6;EFO-21: 7.3;T-47d: 7.5;WM-115: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							HPA044557	Approved		Approved	"Nuclear speckles,Plasma membrane,Mitochondria"				"Plasma membrane"	"Nuclear speckles, Mitochondria"	"HPA044557: AB_10970597"	"unprognostic (4.95e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.81e-4)"	"unprognostic (5.10e-2)"	"unprognostic (6.25e-3)"	"unprognostic (6.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.10e-4)"	"unprognostic (9.30e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.17e-5)"	"unprognostic (2.11e-1)"	0.9	1.2	3.4	0.5	3.6	0.6	0.6	13.6	10.2	0.6	0.6	0.4	0.0	0.5	1.2	0.5	0.4	0.5	1.1	0.3	1.6	2.0	1.1	0.4	0.7	0.4	1.3	5.1	0.6	1.2	0.4	2.5	0.4	2.3	0.6	0.5	0.0	0.4	0.4	0.4	0.5	0.5	0.7	1.1	0.4	0.7	0.9	0.1	0.0	0.5	0.0	0.3	0.5	0.2	0.6	0.6	1.6	0.5	0.3	0.3	0.2	0.0	2.6	0.9	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.0	7.5	0.1	0.1	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.5	0.5	0.5	0.3	0.3	0.2	0.4	0.3	0.2	0.1	0.6	0.3	0.3	1.6	0.3	0.4	0.6	0.2	0.2	3.4	3.6	13.6	7.2	1.6	2.0	1.3	5.1	2.3	0.1
PHLDB3	FLJ40193	ENSG00000176531	"Pleckstrin homology like domain family B member 3"	Q6NSJ2	19	43474954-43504935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043425	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA043425: AB_10797142"	"unprognostic (2.50e-2)"	"unprognostic (4.22e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.60e-2)"	"prognostic favourable (6.36e-6)"	"unprognostic (4.62e-2)"	"prognostic unfavourable (4.11e-5)"	"prognostic unfavourable (5.77e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.37e-1)"	2.7	8.5	6.6	11.7	5.9	3.6	6.0	2.1	5.2	8.7	4.8	1.8	7.1	5.8	8.8	6.5	28.4	7.3	15.9	4.5	5.2	2.9	4.8	9.6	4.0	7.8	3.5	5.8	9.5	7.7	6.8	7.9	6.4	3.2	11.7	2.2	6.7	11.1	7.6	9.0	28.7	9.4	7.5	3.0	6.4	5.4	18.7	3.0	12.2	5.7	15.2	23.2	9.3	14.8	4.4	8.1	0.9	3.3	2.6	5.5	2.3	5.3	5.6	2.4	5.9	2.1	4.4	15.3	3.8	3.4	3.9	2.7	5.7	5.6	3.2	12.2	2.3	6.2	1.7	6.7	0.7	7.5	5.3	3.5	5.4	6.8	5.3	1.3	6.8	3.7	8.6	4.1	2.5	3.4	6.2	4.9	1.9	8.4	5.4	0.3	1.4	4.6	6.4	3.1	2.1	1.8	18.1	0.1	5.1	4.9	10.7	4.6	7.6	4.5	4.3	2.5	6.7	3.0	3.6	12.6	13.7	3.5	2.3	2.6	4.1	0.3	3.3	0.5	4.0	2.3	2.9	3.7	3.7	3.0	6.9	4.4	5.5	4.8	0.9	2.6	0.2	8.1	3.6	2.3	6.6	5.9	2.1	5.2	5.2	2.9	3.5	5.8	3.2	3.0
PLA1A	ps-PLA1	ENSG00000144837	"Phospholipase A1 member A"	Q53H76	3	119597842-119629811	"Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 47.8;epididymis: 63.1;seminal vesicle: 123.8"	"Cell line enriched"	"Detected in some"	18	"SK-MEL-30: 23.4"	"Group enriched"	"Detected in many"	5	"liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"T-reg: 1.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059740			Approved	"Nucleoplasm,Nuclear speckles,Cytoplasmic bodies"	"Secreted in other tissues"			"Nuclear speckles, Cytoplasmic bodies"	Nucleoplasm	"HPA059740: "	"unprognostic (1.35e-1)"	"prognostic favourable (2.81e-7)"	"unprognostic (2.24e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.67e-1)"	2.5	0.4	3.8	1.5	4.7	0.2	1.8	1.4	2.5	2.5	1.3	1.7	47.8	0.6	3.2	63.1	0.8	2.7	1.3	5.0	3.6	4.3	9.3	17.2	13.7	6.1	6.0	1.0	0.5	1.8	11.4	1.0	4.4	7.0	6.0	1.2	10.7	1.5	123.8	10.3	0.3	1.9	4.2	7.4	0.5	2.2	2.0	2.5	0.4	5.0	0.4	3.7	2.1	1.3	0.0	0.0	0.0	0.4	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.7	0.2	0.5	0.1	0.0	0.2	0.0	0.0	23.4	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	0.0	3.8	4.7	1.4	2.5	3.6	4.3	6.0	1.0	7.0	2.5
PNISR	"bA98I9.2, C6orf111, DKFZp564B0769, FLJ14752, SFRS18, SRrp130"	ENSG00000132424	"PNN interacting serine and arginine rich protein"	Q8TF01	6	99398051-99425331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038796, HPA075076"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA038796: AB_10672652, HPA075076: "	"unprognostic (2.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.68e-2)"	"unprognostic (8.55e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.32e-3)"	"prognostic favourable (5.27e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.89e-2)"	"prognostic favourable (1.09e-4)"	24.7	28.5	48.9	28.3	49.8	53.7	29.9	123.3	69.7	35.5	38.3	22.8	39.9	26.7	43.1	58.7	19.8	29.4	22.3	31.0	46.9	17.5	25.5	21.7	26.6	42.2	48.0	29.8	49.3	24.7	34.7	83.9	21.7	41.0	34.1	28.2	24.1	30.8	34.5	39.4	31.9	34.4	31.5	61.0	39.3	28.2	17.4	57.1	32.1	44.7	18.0	30.7	29.5	30.3	18.0	13.1	20.4	7.4	15.6	12.3	2.2	11.3	7.7	41.3	28.3	14.7	21.9	19.1	18.0	9.9	10.8	13.4	13.8	20.7	34.9	12.1	10.1	17.4	20.7	15.7	21.9	28.6	23.1	20.2	38.3	13.8	11.2	28.0	28.7	21.5	22.4	12.0	15.7	15.7	23.5	22.9	14.2	11.4	13.3	32.2	23.1	7.1	26.9	11.6	12.4	21.2	19.7	16.7	22.1	9.0	11.7	15.4	15.6	24.7	17.3	10.9	12.8	10.6	15.4	15.9	11.0	32.0	16.4	28.9	12.6	6.9	7.4	6.6	8.6	4.2	8.5	12.0	8.4	6.8	3.3	18.0	12.3	11.8	20.4	15.6	4.8	13.1	7.7	2.2	48.9	49.8	123.3	69.7	46.9	17.5	48.0	29.8	41.0	57.1
PPP4R3A	"FLFL1, FLJ20707, KIAA2010, MSTP033, PP4R3, SMEK1, smk-1, smk1"	ENSG00000100796	"Protein phosphatase 4 regulatory subunit 3A"	Q6IN85	14	91457611-91510554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002568, HPA063917"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA002568: AB_1079207, HPA063917: "	"unprognostic (5.51e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.40e-2)"	"unprognostic (9.95e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.34e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.53e-2)"	19.0	14.2	22.1	25.7	19.7	48.5	20.1	33.2	22.6	20.6	22.7	15.0	22.0	19.8	22.0	17.7	22.7	21.0	23.4	15.7	19.4	14.2	20.7	27.8	21.4	29.0	20.8	16.8	23.4	21.7	25.6	24.0	25.1	16.3	21.6	20.9	14.7	20.5	29.1	34.8	25.4	27.1	19.9	18.0	29.1	21.2	25.3	18.3	44.6	19.6	20.3	27.5	19.9	25.6	9.0	7.4	8.5	4.7	12.1	10.0	3.6	14.6	17.5	22.1	15.5	12.1	12.1	30.2	12.6	12.4	14.3	14.2	15.1	19.2	33.0	16.1	11.1	15.9	21.5	16.3	22.5	26.8	8.8	16.9	12.3	12.4	13.7	33.1	18.5	8.4	25.2	11.1	16.9	14.5	15.2	24.5	15.9	23.6	24.9	16.0	16.2	12.4	28.9	23.8	14.1	14.4	23.8	25.9	14.2	18.7	45.8	15.8	24.0	19.2	14.3	12.8	11.5	13.1	16.0	18.9	28.3	38.0	15.3	15.6	19.9	8.5	3.1	3.6	7.2	3.5	10.0	7.1	7.3	6.5	2.9	9.0	9.0	7.3	3.4	12.1	4.7	7.4	9.3	3.6	22.1	19.7	33.2	22.6	19.4	14.2	20.8	16.8	16.3	18.3
PPP4R3B	"FLFL2, FLJ31474, KIAA1387, PSY2, SMEK2"	ENSG00000275052	"Protein phosphatase 4 regulatory subunit 3B"	Q5MIZ7	2	55547292-55618880	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001233, CAB017185"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Centrosome"				"Nucleoplasm, Nuclear speckles"	Centrosome	"CAB017185: , HPA001233: AB_1080033"	"unprognostic (9.60e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavourable (6.03e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.77e-1)"	11.9	10.4	12.1	10.6	13.1	8.1	10.9	17.5	13.1	11.2	11.4	8.6	7.4	11.5	8.8	7.8	12.0	12.5	9.1	5.3	12.8		12.7	18.1	8.3	13.0	13.3	7.9	10.8	13.6	10.7	11.7	11.1	11.4	9.5	10.6	7.8	9.6	9.1	6.0	11.0	14.4	10.3	11.1	10.8	11.0	8.0	12.3	18.7	12.6	6.2	14.3	11.3	10.0	17.6	16.9	23.9	19.6	20.0	25.3	21.6	19.7	15.4	17.0	14.3	18.2	19.2	23.4	15.9	17.4	13.8	11.8	18.1	19.1	26.8	32.4	15.7	17.2	19.3	13.1	20.7	38.5	8.1	26.7	14.5	24.2	29.5	30.4	22.2	14.8	31.7	16.8	29.1	21.6	25.3	27.2	18.2	23.1	19.6	20.0	16.7	12.2	18.3	25.7	20.2	19.0	20.7	21.2	12.9	17.3	24.0	25.8	15.1	24.7	16.9	21.2	27.2	10.4	21.9	28.1	21.1	10.3	19.8	29.0	22.5	21.2	15.6	23.9	20.4	19.6	23.0	17.6	21.5	21.2	16.9	16.9	25.3	22.0	18.1	20.0	19.3	9.2	21.5	21.6										
RIOK1	"AD034, bA288G3.1, FLJ30006, RRP10"	ENSG00000124784	"RIO kinase 1"	Q9BRS2	6	7389496-7418037	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017866, HPA051446"	Enhanced		Approved	"Nucleoli,Nuclear speckles,Cytosol"				"Nucleoli, Nuclear speckles"	Cytosol	"HPA017866: , HPA051446: "	"unprognostic (2.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (3.41e-5)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (5.85e-5)"	"unprognostic (2.33e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.12e-3)"	"unprognostic (2.59e-2)"	13.8	10.6	7.7	13.2	13.0	17.5	13.1	12.2	13.5	12.7	11.6	7.3	4.0	7.3	15.4	6.0	15.6	12.3	8.5	11.8	8.0	8.1	8.7	11.7	10.1	14.2	11.6	9.4	13.8	15.3	7.7	17.8	13.9	13.3	10.7	9.6	7.2	10.2	10.3	18.8	12.5	9.9	15.5	9.4	14.4	10.3	21.3	9.2	19.2	10.1	14.7	16.8	10.9	12.6	15.4	14.9	7.7	11.1	18.6	15.0	8.2	7.5	4.4	7.1	16.7	11.1	9.1	10.9	9.5	6.4	8.9	7.4	12.8	3.9	19.7	16.9	7.7	7.7	17.9	7.6	11.4	13.0	19.3	10.5	7.1	13.7	9.4	30.2	13.8	6.7	10.6	9.6	19.8	7.8	26.8	4.6	8.3	9.9	20.5	14.3	15.3	10.4	15.8	9.3	21.4	5.0	7.4	23.7	11.7	8.0	4.8	13.8	7.3	10.0	7.8	9.8	7.4	6.4	14.3	6.4	12.1	29.3	3.0	15.6	14.9	7.7	8.5	5.9	11.5	11.1	13.8	15.2	11.9	12.1	14.9	15.4	13.7	15.0	1.7	18.6	9.7	12.4	11.3	8.2	7.7	13.0	12.2	13.5	8.0	8.1	11.6	9.4	13.3	9.2
RSRC2	FLJ11021	ENSG00000111011	"Arginine and serine rich coiled-coil 2"	Q7L4I2	12	122503458-122527000	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040070, HPA048183"	Uncertain		Approved	"Nucleoli fibrillar center,Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nucleoli fibrillar center, Cytosol"	"HPA040070: AB_10673430, HPA048183: "	"unprognostic (4.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.42e-3)"	"unprognostic (6.90e-2)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.23e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.53e-2)"	18.5	19.4	24.8	20.2	31.9	82.6	20.1	34.9	45.9	19.3	21.0	16.0	19.9	14.3	21.4	21.4	26.9	19.6	21.0	20.2	28.9	21.4	20.6	18.2	19.1	23.0	24.9	24.1	25.2	19.0	11.3	43.2	20.6	28.1	20.0	18.6	10.7	19.1	21.3	36.8	18.7	19.2	20.4	45.1	18.6	16.0	20.7	29.4	21.1	23.5	17.7	15.7	25.0	28.0	24.6	16.3	22.3	18.4	16.4	19.3	9.8	11.7	14.2	13.5	5.7	10.7	7.0	9.7	21.8	7.0	9.4	5.3	19.9	5.0	13.4	18.6	7.6	7.6	14.7	6.1	9.2	12.6	13.6	23.4	17.2	21.2	5.9	20.1	14.3	8.7	7.2	8.0	13.6	6.6	14.9	8.4	8.2	9.4	14.5	15.0	11.1	11.7	11.1	12.2	8.7	12.1	22.1	10.9	9.8	17.0	5.7	12.0	9.2	7.4	9.9	9.6	11.6	10.6	11.9	9.6	22.3	21.6	6.1	11.6	5.4	19.8	16.6	22.3	16.4	13.5	13.9	22.8	15.0	13.3	16.3	24.6	19.3	15.2	17.7	16.4	18.4	15.4	19.0	9.8	24.8	31.9	34.9	45.9	28.9	21.4	24.9	24.1	28.1	29.4
RUFY1	"FLJ22251, RABIP4, ZFYVE12"	ENSG00000176783	"RUN and FYVE domain containing 1"	Q96T51	5	179550558-179610026	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038804	Approved		Supported	"Nuclear speckles,Vesicles,Cytosol"			9600	"Vesicles, Cytosol"	"Nuclear speckles"	"HPA038804: AB_10673290"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.85e-2)"	20.9	27.9	19.7	24.7	22.4	21.1	36.9	22.4	18.9	18.2	20.2	16.9	27.9	16.9	22.5	16.9	25.9	18.8	20.7	14.8	19.7	14.8	23.9	17.5	20.8	23.1	18.8	17.1	19.4	19.8	22.6	21.5	17.3	19.7	20.9	15.5	16.4	21.2	18.3	26.7	24.2	18.8	17.5	14.7	27.9	18.6	12.2	20.5	20.1	27.3	14.1	20.1	20.7	34.3	3.2	3.4	7.9	4.5	1.2	2.9	21.5	7.1	11.8	6.3	8.3	12.2	10.1	7.2	12.7	9.1	7.5	8.8	11.4	16.7	11.6	7.2	15.4	6.6	11.5	16.6	8.9	36.6	8.7	20.2	9.0	8.2	12.5	11.2	11.1	10.2	9.2	5.1	14.6	8.2	8.2	11.1	6.7	21.6	11.9	7.8	6.7	5.5	10.7	4.5	10.7	12.6	11.7	6.3	9.0	18.6	12.0	6.6	9.6	13.8	9.8	10.0	3.3	5.3	9.9	6.9	10.6	20.8	9.2	20.3	9.1	7.4	3.4	7.9	1.7	3.6	1.0	2.7	2.0	1.7	3.0	3.2	1.4	1.8	5.9	1.2	4.5	3.4	2.9	21.5	19.7	22.4	22.4	18.9	19.7	14.8	18.8	17.1	19.7	20.5
SHANK2	"CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3"	ENSG00000162105	"SH3 and multiple ankyrin repeat domains 2"	Q9UPX8	11	70467856-71252577	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.1"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.6;MCF7: 9.5;RT4: 15.4;T-47d: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"basophil: 2.1"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008174, HPA017220"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Vesicles"				"Nuclear speckles"	"Nucleoplasm, Vesicles"	"HPA008174: AB_1856822, HPA017220: "	"unprognostic (3.08e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.23e-5)"	"unprognostic (1.24e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.42e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.01e-1)"	"prognostic favourable (1.94e-6)"	"unprognostic (3.46e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.03e-2)"	"unprognostic (4.80e-2)"	2.1	1.7	16.8	0.8	22.6	0.0	7.3	6.1	24.1	2.8	3.1	2.3	1.9	2.4	1.8	3.1	5.1	7.9	1.1	0.2	12.2	8.1	7.0	4.7	5.5	0.3	3.6	12.9	0.2	11.3	0.0	7.3	2.7	8.7	4.6	2.8	1.4	12.7	3.3	0.1	1.2	2.0	0.6	1.5	1.5	4.7	1.2	3.7	0.0	8.5	0.0	0.5	2.3	0.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	7.7	4.2	0.0	0.4	0.7	3.1	0.6	0.3	0.0	0.0	8.1	2.9	5.1	1.5	0.0	0.8	0.0	2.9	0.0	0.0	0.2	0.0	0.0	8.4	0.0	0.0	1.7	0.2	1.5	0.0	0.0	0.0	0.0	16.6	1.6	9.5	0.0	0.0	3.3	0.3	0.0	7.6	7.5	3.9	15.4	2.5	1.0	0.0	6.2	0.0	11.8	0.0	0.0	0.1	1.2	0.3	0.0	0.1	0.6	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.8	22.6	6.1	24.1	12.2	8.1	3.6	12.9	8.7	3.7
SLC31A2	"COPT2, CTR2, hCTR2"	ENSG00000136867	"Solute carrier family 31 member 2"	O15432	9	113150942-113164137	"Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"blood: 60.2;salivary gland: 125.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 33.0;hTERT-HME1: 22.6;LHCN-M2: 26.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"classical monocyte: 36.6;intermediate monocyte: 50.5;myeloid DC: 21.2;neutrophil: 54.5;non-classical monocyte: 60.2"	"Group enriched"	"Detected in many"	36	"dendritic cells: 21.2;granulocytes: 54.5;monocytes: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014861	Approved		Approved	"Nuclear speckles,Plasma membrane,Intermediate filaments"				"Nuclear speckles"	"Plasma membrane, Intermediate filaments"	"HPA014861: AB_1857098"	"unprognostic (2.26e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.89e-2)"	15.7	8.0	10.0	8.1	20.5	7.0	8.5	3.2	15.0	3.0	8.4	45.1	27.1	5.2	2.0	6.0	4.6	3.0	4.5	3.4	18.2	9.4	9.8	11.2	10.0	6.2	34.3	10.5	2.8	7.8	17.9	1.2	10.2	22.3	2.1	4.4	1.0	125.5	21.8	6.7	18.5	9.9	3.8	48.5	14.1	4.5	5.4	26.2	1.2	2.8	2.9	5.8	3.9	4.1	0.3	21.2	54.5	60.2	0.2	1.2	13.4	5.4	2.4	1.3	2.0	21.7	8.9	4.7	4.1	5.3	5.0	4.8	1.8	1.6	0.3	0.8	3.4	20.2	1.9	11.7	4.7	2.7	0.8	0.3	1.2	2.8	8.3	2.1	1.2	10.0	33.0	11.7	22.6	2.6	1.5	3.0	26.1	5.2	2.1	1.2	0.7	2.3	0.4	19.7	0.3	1.7	3.3	1.2	2.1	5.6	17.5	1.6	6.2	1.9	2.4	2.7	1.9	9.0	3.5	1.8	3.8	0.2	8.7	2.9	2.7	0.8	36.6	3.6	0.9	50.5	1.2	0.2	1.0	1.0	21.2	0.3	0.8	0.8	54.5	0.2	60.2	0.5	0.6	13.4	10.0	20.5	3.2	15.0	18.2	9.4	34.3	10.5	22.3	26.2
SLC4A2	"AE2, BND3L, EPB3L1, HKB3, NBND3"	ENSG00000164889	"Solute carrier family 4 member 2"	P04920	7	151057210-151076527	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.2;retina: 100.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"pons and medulla: 73.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA019339	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles, Plasma membrane"	Cytosol	"HPA019339: AB_1844825"	"unprognostic (1.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (8.12e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (9.04e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favourable (1.26e-4)"	"unprognostic (4.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.36e-2)"	9.9	13.5	4.7	10.4	7.4	6.7	10.5	3.0	8.6	12.4	18.6	29.0	6.0	12.1	16.2	6.3	7.7	10.8	14.1	11.9	10.1	3.8	35.5	94.2	12.3	7.2	10.4	4.8	12.6	34.1	30.6	5.3	31.4	73.3	10.5	4.0	100.7	11.9	8.3	8.7	9.5	26.0	10.7	10.4	10.1	27.1	6.5	8.5	8.8	9.7	7.0	5.9	11.7	10.6	2.5	5.6	2.1	4.2	0.5	2.7	1.9	15.6	51.8	10.2	21.0	10.2	6.0	23.3	19.0	10.3	15.6	13.5	29.5	25.1	9.4	41.8	9.0	15.4	10.4	9.2	2.9	27.1	15.5	12.3	25.2	15.0	16.7	6.3	39.8	8.7	8.1	17.7	4.5	8.7	38.2	8.0	12.0	30.1	18.2	11.0	24.3	19.3	14.4	5.6	11.0	12.7	11.9	8.4	30.6	17.4	32.9	16.2	13.6	12.6	18.6	21.0	10.7	20.6	28.0	8.6	11.6	5.3	32.1	16.0	42.1	0.0	4.2	2.1	2.7	3.9	1.9	2.5	2.1	1.8	2.4	1.0	2.4	2.4	1.0	0.5	2.5	5.6	1.0	1.9	4.7	7.4	3.0	8.6	10.1	3.8	10.4	4.8	73.3	8.5
SNRPA1	Lea1	ENSG00000131876	"Small nuclear ribonucleoprotein polypeptide A'"	P09661	15	101281510-101295282	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045622, HPA048499"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Nuclear bodies"				Nucleoplasm	"Nuclear speckles, Nuclear bodies"	"HPA045622: , HPA048499: "	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (8.56e-5)"	"unprognostic (5.80e-2)"	"unprognostic (1.66e-3)"	"prognostic favourable (8.83e-5)"	"unprognostic (4.74e-2)"	"unprognostic (6.77e-3)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.37e-2)"	11.9	13.3	12.4	26.1	19.6	35.2	17.7	9.7	17.2	9.9	18.0	10.2	10.4	14.6	14.3	21.1	24.6	12.4	11.8	17.3	17.9	9.8	16.1	19.7	14.1	29.2	11.2	12.2	10.8	16.3	9.1	10.7	29.3	14.1	10.3	19.3	11.3	17.2	9.1	13.4	12.1	22.5	11.7	9.4	26.4	15.9	24.3	7.0	33.4	11.6	18.1	30.0	12.3	12.2	21.7	23.5	8.4	18.2	18.3	26.9	15.3	31.2	21.9	21.1	10.7	6.0	4.9	20.8	29.1	13.5	26.2	20.0	46.7	28.0	34.8	16.7	19.7	18.7	31.5	20.8	28.1	17.6	48.7	27.3	35.6	24.6	4.6	31.2	19.6	4.0	15.6	16.7	21.1	16.8	37.9	32.8	16.0	34.6	31.4	33.2	27.0	18.6	31.4	22.8	35.0	19.1	82.2	16.5	17.3	17.7	20.3	21.9	19.6	24.7	12.1	14.0	26.6	16.3	29.0	27.1	80.2	67.6	11.3	29.5	16.5	1.4	15.0	8.4	24.6	18.2	24.1	21.7	25.4	24.2	23.5	19.1	21.2	26.3	2.9	18.3	16.6	22.3	26.9	15.3	12.4	19.6	9.7	17.2	17.9	9.8	11.2	12.2	14.1	7.0
SYNPO2L	FLJ12921	ENSG00000166317	"Synaptopodin 2 like"	Q9H987	10	73644881-73663803	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.5;HSkMC: 6.0;RH-30: 5.8;SK-BR-3: 6.1"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA055192, HPA057142"	Enhanced		Supported	"Nuclear speckles,Cell Junctions,Cytosol"				"Nuclear speckles"	"Cell Junctions, Cytosol"	"HPA055192: , HPA057142: "	"unprognostic (2.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-1)"	3.8	0.1	0.0	0.0	0.1	0.1	1.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	3.2	3.3	0.0	0.0	69.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.8	0.0	0.0	1.6	0.0	72.8	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.3	29.3	3.4	0.0	0.3	0.7	1.0	3.0	0.7	0.7	0.7	0.1	0.5	0.1	0.8	0.2	0.1	0.0	1.1	0.9	1.2	0.2	0.0	7.5	0.7	0.3	0.5	0.9	0.1	0.1	0.0	0.4	0.1	0.2	0.3	0.6	0.4	0.6	0.2	0.2	6.0	0.1	1.2	0.1	0.0	0.3	0.3	0.3	0.3	0.2	1.8	0.2	0.7	0.2	5.8	0.2	0.0	0.6	0.3	0.4	0.1	6.1	0.1	0.4	0.7	0.0	0.6	1.0	0.2	0.3	1.0	0.3	0.3	0.2	0.6	0.0	2.9	0.7	0.7	0.7	0.4	0.3	0.5	0.3	0.3	0.2	0.7	0.4	0.4	3.0	0.7	0.4	1.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0
TEPSIN	"C17orf56, ENTHD2, FLJ31528"	ENSG00000167302	"TEPSIN, adaptor related protein complex 4 accessory protein"	Q96N21	17	81228277-81239091	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063410			Supported	"Nuclear membrane,Nuclear speckles,Golgi apparatus"				"Nuclear membrane, Nuclear speckles, Golgi apparatus"		"HPA063410: "	"unprognostic (6.90e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (9.96e-4)"	"unprognostic (1.16e-2)"	"unprognostic (4.85e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.29e-1)"	"prognostic favourable (6.95e-4)"	"unprognostic (4.99e-2)"	"prognostic unfavourable (7.31e-8)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.16e-3)"	8.5	6.7	8.0	11.9	8.5	17.3	21.3	11.9	9.8	6.0	9.9	9.0	7.3	14.9	7.9	8.6	8.8	8.0	6.6	4.9	8.8	4.7	9.8	13.3	12.5	13.5	12.5	6.3	6.8	11.1	5.3	9.2	7.7	9.8	10.1	6.5	4.8	9.1	9.3	12.4	15.8	12.4	9.8	8.5	17.0	9.7	9.1	9.8	12.2	12.6	7.5	9.0	7.2	7.0	3.0	2.7	7.6	2.9	0.7	1.8	1.2	8.7	12.9	5.0	8.1	3.5	5.8	10.0	7.8	4.4	7.8	7.2	8.3	6.2	6.3	4.4	5.2	11.4	5.2	6.6	3.8	3.8	17.1	5.2	7.2	11.9	5.2	5.6	10.9	3.0	8.6	3.6	4.1	12.4	6.4	6.2	5.0	7.6	10.5	13.0	5.5	11.1	6.6	6.6	6.9	3.0	5.6	6.7	7.8	9.3	10.2	10.7	6.9	10.1	7.9	10.6	6.1	8.1	7.4	8.4	5.8	4.7	7.8	4.8	5.2	4.2	2.4	7.6	1.8	2.9	1.1	2.5	1.2	1.4	2.7	3.0	0.8	0.8	4.3	0.7	1.9	2.7	1.6	1.2	8.0	8.5	11.9	9.8	8.8	4.7	12.5	6.3	9.8	9.8
TERT	"EST2, hEST2, TCS1, TP2, TRT"	ENSG00000164362	"Telomerase reverse transcriptase"	O14746	5	1253147-1295069	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"DNA-binding, Nucleotidyltransferase, Ribonucleoprotein, RNA-directed DNA polymerase, Transferase"	"Cancer-related genes, Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.4;lymphoid tissue: 12.0;testis: 5.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 61.2;fHDF/TERT166: 58.1;HBEC3-KT: 118.1;hTEC/SVTERT24-B: 74.6;LHCN-M2: 33.7;TIME: 96.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA054641, HPA065897"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA054641: , HPA065897: "	"unprognostic (1.21e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (9.16e-4)"	"unprognostic (8.84e-11)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-1)"		"unprognostic (3.35e-1)"	0.0	0.0	0.0	7.1	0.9	3.4	0.0	0.0	0.2	0.1	1.1	0.0	0.0	1.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	1.0	0.4	5.0	0.0	12.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	30.6	61.2	0.5	0.0	23.3	4.2	7.9	0.1	0.1	0.7	0.0	58.1	0.0	0.2	118.1	5.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.2	0.0	3.0	74.6	0.8	0.2	0.6	0.1	33.7	0.0	0.2	1.6	0.4	0.2	0.8	0.0	0.8	3.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	96.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0
THBS2	TSP2	ENSG00000186340	"Thrombospondin 2"	P35442	6	169215780-169254044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 84.6;urinary bladder: 67.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 81.9;ASC TERT1: 56.2;BJ hTERT+ SV40 Large T+ RasG12V: 27.2;HSkMC: 30.3;hTEC/SVTERT24-B: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017716, HPA044304"	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		22000000	"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB017716: , HPA044304: "	"unprognostic (2.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavourable (3.77e-6)"	"unprognostic (2.19e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.48e-3)"	43.5	4.0	4.3	10.1	7.8	0.4	84.6	1.1	9.0	24.3	17.0	6.3	3.3	1.9	26.1	16.1	9.8	14.8	43.0	21.9	5.5	3.6	4.6	5.9	8.4	3.8	8.1	1.4	26.2	5.9	1.5	4.4	2.0	14.8	10.5	3.4	0.7	3.9	2.8	14.6	22.7	3.8	22.0	16.0	2.8	2.6	12.5	5.2	0.0	13.2	10.6	4.8	67.4	29.4	0.4	0.7	0.2	0.8	0.1	0.3	0.0	0.0	0.0	0.5	0.3	81.9	56.2	0.0	15.6	21.4	21.6	27.2	0.1	0.0	0.0	0.0	18.6	0.0	0.6	0.8	12.4	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	30.3	0.0	29.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.8	3.3	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.9	0.1	22.0	1.8	0.0	0.3	0.0	6.1	0.1	0.5	0.0	0.8	0.2	0.2	0.5	0.0	0.4	0.1	0.0	0.2	0.3	0.1	0.3	0.0	0.1	0.5	0.7	0.2	0.0	4.3	7.8	1.1	3.1	5.5	3.6	8.1	1.4	14.8	5.2
TMEM209	"FLJ14803, NET31"	ENSG00000146842	"Transmembrane protein 209"	Q96SK2	7	130164715-130207770	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031678	Uncertain		Approved	"Nuclear membrane,Nuclear speckles,Vesicles"				"Nuclear membrane, Nuclear speckles, Vesicles"		"HPA031678: AB_10603135"	"unprognostic (3.03e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.50e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.24e-1)"	12.0	33.5	9.9	9.1	12.1	9.4	12.2	12.7	13.3	9.4	12.2	23.8	9.5	10.4	16.4	11.8	8.8	11.2	8.1	7.9	9.9	10.9	11.6	16.9	10.3	12.2	11.6	12.0	13.7	19.8	19.0	18.7	18.6	16.4	10.3	12.9	19.0	16.5	10.3	10.1	11.1	19.0	10.5	19.1	13.3	8.8	17.8	11.3	24.9	18.6	8.0	13.1	11.1	8.9	14.1	10.8	10.0	13.4	13.8	20.5	10.4	9.4	9.1	12.4	15.3	7.2	7.4	9.2	8.6	8.7	7.9	10.6	10.1	17.2	14.0	6.5	5.5	14.2	14.5	10.0	14.1	17.3	8.3	7.3	15.4	6.7	12.8	15.3	7.4	8.2	10.3	15.7	15.7	6.0	23.5	16.5	9.5	12.3	29.1	9.3	18.5	8.1	15.7	13.9	23.2	7.9	12.1	11.1	17.1	19.7	31.7	12.5	10.2	10.3	4.7	14.4	5.6	15.0	20.7	22.0	32.2	29.2	23.4	17.7	22.1	10.0	8.9	9.5	17.0	13.4	17.7	14.1	17.4	15.4	8.6	14.0	20.5	17.3	1.3	13.8	11.3	10.8	17.3	10.4	9.9	12.1	12.7	13.3	9.9	10.9	11.6	12.0	16.4	11.3
TSC22D3	"DIP, DSIPI, GILZ, hDIP, TSC-22R"	ENSG00000157514	"TSC22 domain family member 3"	Q99576	X	107713221-107777342	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 57.8;ASC TERT1: 39.8;HHSteC: 95.7;hTCEpi: 85.2;Karpas-707: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001916, CAB034364"	Approved		Approved	"Nuclear speckles,Golgi apparatus,Cytosol"				Cytosol	"Nuclear speckles, Golgi apparatus"	"CAB034364: AB_2272198, HPA001916: "	"unprognostic (3.67e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.99e-2)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (3.49e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.73e-3)"	"unprognostic (4.40e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.25e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.37e-3)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-1)"	"unprognostic (9.64e-2)"	69.1	48.4	18.2	72.7	21.0	72.4	142.4	31.8	32.7	53.3	49.0	10.6	36.7	16.7	37.2	26.6	58.7	45.4	47.8	42.6	18.8	12.2	33.8	20.9	83.3	98.8	22.0	16.2	54.6	20.0	7.1	18.8	31.3	20.8	51.8	37.2	39.8	172.4	40.7	163.5	65.2	54.6	45.4	22.9	55.7	49.3	20.3	19.2	29.7	59.8	36.1	62.7	75.3	89.6	47.9	31.7	191.5	62.4	69.0	82.4	105.1	1.5	2.6	1.3	3.7	57.8	39.8	0.5	2.4	2.0	1.1	1.2	0.0	5.2	3.3	6.0	1.9	7.8	2.8	7.8	0.5	1.0	1.3	1.6	11.0	0.1	95.7	0.3	5.6	36.2	85.2	0.9	23.8	4.3	0.5	53.8	9.8	5.3	0.1	5.7	2.4	1.7	0.1	3.4	7.0	3.8	1.0	0.3	3.0	2.4	13.2	18.1	2.5	7.5	6.4	3.5	1.0	0.7	0.4	11.8	5.1	1.5	1.8	6.7	0.9	42.7	34.0	126.9	55.2	40.4	40.6	47.9	63.4	53.6	31.7	45.5	59.6	55.4	191.5	69.0	62.4	6.4	82.4	105.1	18.2	21.0	31.8	32.7	18.8	12.2	22.0	16.2	20.8	19.2
TTC26	"dyf-13, DYF13, FLJ12571, IFT56"	ENSG00000105948	"Tetratricopeptide repeat domain 26"	A0AVF1	7	139133744-139191986	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036338, HPA036339"	Enhanced		Approved	"Nuclear speckles,Intermediate filaments,Cytosol"				"Nuclear speckles, Intermediate filaments, Cytosol"		"HPA036338: AB_10673351, HPA036339: AB_10673386"	"unprognostic (3.40e-2)"	"unprognostic (8.88e-2)"	"unprognostic (5.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.46e-7)"	"unprognostic (1.72e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.56e-1)"	3.5	6.5	6.9	2.5	8.1	3.3	5.6	6.9	8.3	6.1	3.1	4.4	7.4	1.3	6.6	7.6	3.1	20.9	4.5	3.5	5.7	5.1	8.3	1.9	5.1	2.8	2.7	4.8	8.8	3.2	13.0	20.1	3.8	8.4	5.6	2.8	5.4	3.6	5.5	2.3	3.2	2.2	4.6	2.7	2.6	3.1	17.4	3.9	3.8	7.3	2.8	3.1	3.7	3.9	3.6	2.5	5.3	1.5	1.6	2.3	0.9	11.3	8.6	7.6	9.0	9.5	11.1	3.8	5.5	5.8	9.1	9.3	5.5	8.2	2.5	9.3	4.3	5.7	8.5	6.5	13.3	7.1	7.3	3.1	6.9	4.7	4.7	8.8	2.1	6.3	5.9	13.6	6.2	6.7	6.8	1.6	7.2	10.7	14.9	10.3	7.6	7.6	5.2	9.0	4.0	7.9	3.4	11.2	8.0	13.7	5.8	7.8	7.0	4.7	4.6	8.5	7.4	7.7	10.2	3.7	4.6	1.9	14.9	4.3	9.9	1.2	0.5	1.2	2.1	0.5	1.1	3.6	1.5	1.4	1.1	2.4	2.3	1.7	5.3	1.6	1.5	2.5	1.0	0.9	6.9	8.1	6.9	8.3	5.7	5.1	2.7	4.8	8.4	3.9
YTHDF3	FLJ31657	ENSG00000185728	"YTH N6-methyladenosine RNA binding protein 3"	Q7Z739	8	63168553-63212786	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048703			Approved	"Nuclear membrane,Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nuclear membrane, Cytosol"	"HPA048703: "	"unprognostic (1.06e-2)"	"unprognostic (9.89e-3)"	"unprognostic (6.65e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.87e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.11e-1)"	21.7	17.5	12.2	12.8	15.2	53.2	16.0	16.7	17.3	19.4	20.2	14.3	16.8	14.2	24.3	13.6	17.7	17.6	17.6	26.9	11.9	11.4	18.8	26.8	16.8	12.4	14.2	10.6	25.1	15.6	16.6	19.3	29.0	16.8	21.2	15.6	12.9	18.1	18.8	28.0	12.7	24.7	19.4	14.4	18.1	15.9	13.3	14.2	20.1	17.2	15.9	14.1	21.0	15.9	8.2	16.9	21.2	24.9	9.7	11.0	10.1	16.0	21.8	21.0	15.8	28.1	24.2	14.4	29.3	24.6	18.6	22.1	18.5	16.1	17.0	6.4	28.5	15.4	27.6	19.5	27.7	13.8	13.1	31.6	16.5	12.5	25.6	9.0	15.6	32.0	15.0	19.9	27.9	15.7	18.5	15.6	27.9	11.1	17.2	8.4	29.2	16.1	13.1	16.1	8.4	17.5	28.5	8.6	15.4	20.8	18.8	21.2	25.2	11.4	28.2	17.4	16.8	15.5	15.7	18.8	17.0	25.5	17.7	12.7	20.9	20.6	16.6	17.4	8.9	19.4	9.8	7.4	9.0	10.5	16.9	8.2	11.0	10.5	21.2	9.7	24.9	5.1	9.4	10.1	12.2	15.2	16.7	17.3	11.9	11.4	14.2	10.6	16.8	14.2